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Perceived exertional dyspnoea is reported to be the most common symptom among 
physically active individuals of all abilities and ages and/or performance in high level 
athletes, potentially impacting on performance and limiting enjoyment of sporting 
activities. Identifying the causes of the perceived symptoms requires careful assessment 
with a wide range of factors potentially contributing to the reported respiratory issues. 
The purpose of this thesis was to investigate different assessment approaches in the 
identification of breathing dysfunction in exercising adults.  
 
Elite swimming and boxing require athletes to achieve relatively high minute ventilation. 
In Chapter 4 (Study 1 of this thesis), thirty-eight elite boxers and 44 elite swimmers 
completed a thorough respiratory assessment that revealed a nine-fold greater prevalence 
of exercise-induced bronchoconstriction in swimmers when compared with boxers. These 
results suggested that the combination of a sustained high ventilation and provocative 
training environment may impact the susceptibility of athletes to this condition. 
 
Dysfunctional breathing may mimic and/or co-exist with exercise-induced 
bronchoconstriction. The use of specific questionnaires may improve the identification of 
this condition in athletes. In Chapter 5 (Study 2 of this thesis), 9% of the 428 healthy, 
physically active young adults who completed the Nijmegen Questionnaire had a score ≥ 
23, suggestive of a dysfunctional breathing status. A separate cohort of 104 athletes 
underwent an indirect bronchoprovocation challenge and completed the Nijmegen 
questionnaire. The sensitivity, specificity, positive and negative predicted values 
suggested that the Nijmegen score was a poor predictor of a positive bronchoprovocation 
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challenge in athletes and therefore is not suitable to detect dysfunctional breathing in 
athletes. 
 
The posture an athlete holds during exercise may alter breathing pattern and increase 
reported exercise induced respiratory symptoms. In order to investigate whether 
respiratory parameters are affected by different postural positions, in Chapter 6 (Study 3 
of this thesis), 15 healthy male athletes performed a 10-minute, high intensity cycling test 
with normal shoulder position and with hunched shoulders. Results of this study showed 
that cycling with hunched shoulders at high intensities over a prolonged period leads to 
an increase in perceived dyspnoea and suggested that posture may contribute to reports 
of respiratory symptoms during exercise in the absence of cardio-pulmonary disease. 
 
With the aim of investigating the effect of different postural positions on the ventilatory 
excursion, in Chapter 7 (Study 4 of this thesis), 15 healthy male athletes performed 
baseline spirometric measurements and 10-minutes cycling challenges with normal 
shoulder position and with hunched shoulders, while undergoing simultaneous data 
collection with optoelectronic plethysmography. The findings of this study suggested that 
respiratory excursion and lung volume compartmentalisation at both rest and during high 
intensity exercise are affected by the position of the shoulders. 
 
In conclusion, athletes who train and compete in provocative environments at a sustained 
high ventilation have an increased susceptibility to airway dysfunction. No existing 
questionnaire is sensitive enough to identify dysfunctional breathing and differentiate it 
from other respiratory conditions, such as exercise-induced bronchoconstriction. 
Exercising for a prolonged period at high intensities with hunched shoulders triggers 
 vii 
increased abdominal contribution to vital capacity and a subsequent increase in 
perception of breathing sensation without a significant effect on physiological markers of 
respiratory function. 
 
Further investigations should be undertaken in order to develop a new questionnaire that 
is more suitable for an athletic population and has higher accuracy in identifying 
symptoms associated with exercise induced breathing impairment. Precise detection of 
distortions between compartmental contributions in exercising individuals may play an 
important role in the differential diagnosis of dysfunctional breathing.
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The health benefits of regular exercise and physical activity are well known, however 
frequent, repeated periods of high minute ventilation (V̇E) in certain environmental 
conditions might be disadvantageous to an individualÕs respiratory health (Hull et al., 
2012). Respiratory symptoms (e.g. breathlessness, phlegm production, wheeze and 
cough) are common in athletes of all abilities. Turcotte et al. (2003) showed that one in 
four athletes has complaints of regular, troublesome respiratory symptoms. Moreover, 
primary care physicians in the UK see dyspnoeic athletes at a frequency of approximately 
one case per calendar month (Hull et al., 2012). 
 
Many factors can limit pulmonary performance and produce symptoms of respiratory 
discomfort (Bussotti et al., 2014), the pathogenesis of which, is still not clearly 
understood. Currently, in the lack of objective, gold standard diagnostic methods and 
algorithms, diagnosis is often made solely on the basis of complaints and previous 
medical history alone. Moreover, the subjectivity of symptoms makes it difficult for the 
physicians to accurately identify and judge the severity of the underlying condition(s). 
These factors may contribute to a potential diagnostic delay and a possible failure to 
determine the specific cause of respiratory dysfunction, especially in those individuals 
whose symptoms are multifactorial.  
 
In the absence of extensive differential diagnostic tools, healthcare professionals face 
with a major challenge when attempting to distinguish among the perception of symptoms 
that fall within a spectrum of what could be considered a normal physiological response 
to intense exercise (Hull et al., 2012), those indicating underlying cardiorespiratory 
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pathology and complaints linked to a non-pathological and/or non-organic problem or 
other contributing factors.  
 
In healthy humans the structural characteristics of the respiratory muscles and the neural 
control of breathing are almost ideally designed and regulated to meet the demands for 
increased ventilation during exercise (Aliverti et al., 1997). However, although maximal 
expiratory flow rates are usually greater than the spontaneous flow rates reached during 
maximal exercise, endurance trained individuals with high maximal exercise ventilation 
may develop expiratory flow limitation (EFL) alongside a series of secondary 
manifestations such as dyspnoea, hypercapnia and consequent exercise limitation. 
Increased work of breathing during heavy sustained exercise may encroach on the 
capacity of the respiratory system by placing a load on the respiratory muscles (Harms et 
al., 2000, Dempsey et al., 2008). Fatigue of these muscles, particularly of the diaphragm, 
can have a vasoconstrictor effect on limb muscle vasculature compromising locomotory 
muscle blood flow, O2
 
uptake and the overall performance (Bussotti et al., 2014, 
Dempsey et al., 2008, Harms et al., 1997). 
 
Breathlessness is a complex set of symptoms that are often related to the strength or 
intensity of the sensation (sensory component) and how unpleasant the sensation feels 
(emotional component). Both components are influenced by the changes in ventilation, 
but they may operate independently (Faull et al., 2016). Moderate to severe breathlessness 
is well-recognised as a normal sensation during intense exercise in otherwise healthy 
individuals (Borg et al., 2010, Hamilton et al., 1996). The sensation of Òbeing out of 
breathÓ is usually considered non-threatening due to precise matching between 
expectation and the actual ventilatory response to heavy exercise (Faull et al., 2016).  
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However, the increase in respiratory work may be perceived abnormal by those who 
experience discomfort and find that it limits their ability to perform to their expectations. 
It has been suggested that the affective components of breathlessness and the resultant 
anxiety when nearing maximal ventilation may be a key factor within the complex 
limitations of athletic performance in those, who are highly-trained (Faull et al., 2016, 
Harms et al., 1997, Harms et al., 2000). There might be an exaggerated perception of the 
intensity of breathlessness in individuals who, addition to the high levels of anxiety, 
experience multiple somatic complaints due to underlying pathological cardiorespiratory 
problems or non-organic issues. 
 
Exercise-induced bronchoconstriction (EIB) is a common diagnosis in active individuals 
with complaints of dyspnoea, fatigue or poorer than usual performance during exercise 
(Smoliga et al., 2016). The occurrence of EIB is independent of age and fitness level and 
has a prevalence rate of about 10 to > 50% or greater in competitive athletes (Johansson 
et al., 2015, Parsons & Mastronarde, 2005). Exercise-respiratory symptoms such as 
cough, wheeze and chest tightness, however are not exclusive to only EIB; they can also 
be associated with exercise-induced laryngeal obstruction (EILO), hyperventilation 
syndrome (HVS) and dysfunctional breathing (DB) (Boulding et al., 2016). Although 
there exist well established guidelines for the diagnosis and management of EIB, due to 
the non-specific nature of the signs and symptoms, and the lack of gold standards to 
differentiate among the aforementioned conditions, it is frequently misdiagnosed in 
clinical practice (Smoliga et al., 2016) and as a consequence the underlying condition 




Previous researches (Rundell et al., 2001, Parsons et al., 2011, Weiler et al., 2014, 
Simpson et al., 2015) have shown that the diagnosis of exercise-induced airway 
dysfunction using self-reported symptoms leads to a significant number of false-positive 
(17 - 39%) and false-negative rates (12 - 15%) (Rupp et al., 1992, Rupp et al., 1993) and 
such self-reports do not correlate with changes in airway calibre in athletes with EIB 
(Simpson et al., 2015). These findings highlight the importance of recognising the poor 
predictive value of symptoms and suggest to avoid basing a diagnosis on the evaluation 
of clinical features alone in order to protect athletes from the continuation or progression 
of symptoms. That could potentially lead to impaired performance and/or discontinuation 
of sport (Weiler et al., 2014).  
 
Accurate identification of the causative factors contributing to the exercise-respiratory 
symptoms is crucial in order to ensure that optimum care is delivered to this specific 
population. This thesis therefore will attempt to investigate various diagnostic methods 
that would assist practitioners in identifying and differentiating between pathological and 
non-pathological causes and contributing factors of breathing dysfunction.  
 
Specifically, investigations will be undertaken in order to explore whether environmental 
factors would affect the prevalence of airway dysfunction in high level sports and if the 
Nijmegen questionnaire is sensitive enough to distinguish between EIB and DB. It will 
also aim to study whether breath-by-breath analysis and/or optoelectronic 
plethysmography can detect physiological changes, if there exists any, when body 




In this current thesis, the term Òphysically active individualÓ will be used to describe those 
who exercise at least two times a week, a Òrecreational athleteÓ is somebody who 
exercises 2-5 times a week and competes regularly at regional and/or national level and 
Òelite athletesÓ are those individuals who train 5-7 days a week, compete regularly in 








The act of breathing is unique in that it is considered as the only vital function that can 
be under both automatic and voluntary control (Gilbert, 1999, Butler, 2007, American 
Thoracic Society, 1999). It is regulated not only by automatic centres located in the 
brainstem, but also by sleep-wake cycles, environmental, emotional and volitional signals 
initiated in the cortex (Butler, 2007). The automatic and voluntary control nature of 
breathing is advantageous; enables complex and precise changes in breathing when 
speaking, eating or breath holding (Butler, 2007). Although most of the time individuals 
are unaware of their breathing, changes in the natural process of respiration due to 
physiological or psychological factors can affect an individualÕs sense of well-being 
(Gilbert, 1999). 
 
Breathing is dependent upon the coordinated efforts of the breathing muscles (Benditt, 
2006) and alterations in their function may reduce the effectiveness of ventilation 
(Ratnovsky et al., 2008). Posture, as a component of any position and every movement 
of locomotion, is considered to be an active, central nervous system (CNS) controlled 
maintenance of body segments against the action of external forces, from which gravity 
has the greatest impact (Chiba et al., 2016). Although the major function of the respiratory 
muscles is to contribute to inhalation and exhalation, they are also actively involved in 
postural movements of the torso (Butler, 2007). Disruption in one of these functions could 
negatively affect the other (Hodges et al., 2007) and as a consequence, individuals with 
poor posture may exhibit signs of faulty breathing mechanics in the absence of underlying 
cardio-respiratory diseases.  
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Breathing can be considered as an independent variable that affects emotion, cognition 
and behaviour, but also as a dependent variable that reflects changes in these parameters 
(Ley, 1994). Conscious or unconscious changes in breathing can affect both our feelings 
and thoughts. For example, breathing intensifies when an increased metabolic demand 
occurs (e.g. in exercise) but also due to an emotional impact (e.g. anger, fear or anxiety) 
(Ley, 1994). For instance, excessive breathing with an upper chest breathing pattern can 
be triggered by an acute stress reaction (e.g. anxiety) and generate unpleasant sensations 
such as dyspnoea, pain or chest tightness (Gilbert, 1999). 
 
2.2 Breathing pattern 
 
In this thesis, the term Òbreathing patternÓ will exclusively be referring to the relationship 
of the thoraco-abdominal compartments to each other during an individualÕs breathing 
without considering any other parameters such as breathing frequency (BF) or volume.  
 
Konno and Mead (1967) previously described the chest wall as a system of two moving 
compartments (ribcage and abdomen) with only one degree of freedom each. They 
suggested that when known air volume is inhaled and measured with a spirometer, 
volume-motion relationship can be expressed as the sum of the abdominal and rib cage 
displacements (Konno & Mead, 1967). Although the Konno-Mead model has been 
integrated in most available technology that aims to assess chest wall movements, its 
major limitation is that it disregards the axial displacements of the torso associated with 
postural movements of the spine and pelvis and only considers changes in the antero-
posterior diameter of the chest wall, meaning that valuable information of the respiration 
may not be assessed.  
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To date, there are no standardised reference values of respiratory movements available 
(Kaneko & Horie, 2012). Previous studies show a wide range of variation in the ribcage 
contribution to the movement in healthy individuals (Verschakelen & Demedts, 1995), 
depending on whether they were assessed in a supine (20 - 45%), sitting (40 - 70%) or 
standing (50 - 70%) position (Lumb & Nunn, 1991, Courtney et al., 2008, Sharp et al., 
1975, Vellody et al., 1978). A limitation in most of these studies is that they do not specify 
whether the participants are using any support for their upper body at the time the 
breathing pattern is measured. When sitting or standing with support, the diaphragm can 
focus more on the breathing than on the postural function (Price et al., 2014a).  
 
Ribcage motion may decrease with increasing age (Kaneko & Horie, 2012), however this 
does not appear to influence any other parameters of breathing (Verschakelen & Demedts, 
1995, Sharp et al., 1975, Ragnarsdottir & Kristinsdottir, 2006). Similarly, some studies 
indicate that males have lower percentages of rib cage movement than females (Kaneko 
& Horie, 2012, Ragnarsdottir & Kristinsdottir, 2006, Romei et al., 2010), however 
respiration appears not to be affected by gender (Verschakelen & Demedts, 1995, Sharp 
et al., 1975). The discrepancies that pertain to the effects of body position, age and gender 
might be related to the type of measuring instrument used in different studies (Kaneko & 
Horie, 2012). Regardless, a deviation away from the breathing pattern that is optimal for 
the given individual can affect the pressure, ventilatory volumes, stability and ultimately 
the work of breathing. Barker & Everard ( 2015) have previously claimed that once the 
maladaptive pattern is established, the impaired breathing movement becomes habituated 
and thus a self-perpetuating entity. As a consequence, these individuals develop 
symptoms of dysfunctional breathing that, by being intermittently or in some cases 
constantly present, contribute to a negative impact on everyday life. 
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2.3 Dysfunctional breathing (DB) 
 
2.3.1 Description and definition 
 
Dysfunctional breathing is a term used to describe a variety of breathing disorders where 
an inefficient breathing pattern is adopted and often results in reports of respiratory 
symptoms (e.g. dyspnoea, wheeze and chest tightness) and non-respiratory symptoms 
(e.g. anxiety, lightheadedness and fatigue) (Boulding et al., 2016).  
 
Normal breathing, also known as diaphragmatic breathing, involves synchronised motion 
of the upper rib cage, lower rib cage, and abdomen (Bradley & Esformes, 2014) and 
requires adequate use and functionality of the respiratory muscles (Pryor & Prasad, 2008). 
Conversely, breathing dominantly with the upper chest results in abnormal or so called 
thoracic breathing, that involves greater upper rib cage motion compared to the lower rib 
cage (Gilbert & Chaitow, 2002). It has been suggested that both physiological and 
psychological factors can cause prolonged changes and deviation from the normal 
breathing pattern (Tobin et al., 1983). If abnormal breathing patterns are retained after 
the exclusion or treatment of the conditions that may have initiated their occurrence, is 
considered a DB pattern (Courtney, 2009). The extent of upper chest dominant breathing 
seems to be an important cause of accompanying symptoms such as breathlessness, 
dyspnoea and chest tightness (Courtney et al., 2011b), the presence of which can result 
in anxiety that may provoke further breathing irregularity (Ley, 1994).  
 
The abnormal afferent proprioceptive input associated with upper chest dominant 
breathing can directly result in the perception of respiratory symptoms (Howell, 1997, 
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Thomas & Bruton, 2014). One hypothesis is that sensations of breathlessness and 
dyspnoea arise from mismatch between the brainÕs movement control (motor output) and 
sensory system (sensory input) resulting in dissociations between what the brain expects 
and what it receives from receptors in the respiratory muscles (Laviolette et al., 2014). In 
addition, an upper chest breathing pattern is generally associated with dynamic 
hyperinflation (Barker & Everard, 2015, CliftonSmith & Rowley, 2011, Gardner, 1996), 
which, due to the increases in the elastic recoil of the lungs and the chest, alongside an 
often increased breathing rate, leads to larger respiratory work. These processes, by 
reducing the economy of movement (e.g. flattening the diaphragm and shortening the 
muscle fibres), cause biomechanical changes that negatively affect the respiratory 
muscles (Lumb, 2016). As a result, symptoms of breathlessness, dyspnoea and chest 




Boulding et al. (2016) has previously claimed that in the absence of established diagnostic 
criteria, it is not possible to accurately interpret the reports of DB incidence rates.  Thomas 
et al. (2001, 2005) previously suggested that DB affects 29% of asthmatics and 8% of 
those without asthma. They merged these two datasets to estimate the prevalence of DB 
in the general population, which they calculated was 9.5% (Thomas et al., 2005). Gender 
differences have been documented in relation to DB, with a study showing that in a non-
asthmatic population, 14% of women but only 2% of men have symptoms suggestive of 
DB (Thomas et al., 2001). These percentages are increased among asthmatic adults with 
an incidence rate of 35% for women and 20% of men (Thomas et al., 2001), but remains 
similar in asthmatic children (13% females and 2% males)(de Groot et al., 2013).  
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2.3.3 Differential diagnosis of DB 
 
Dysfunctional breathing can manifest alone or in association with other diseases 
(Courtney et al., 2011a). The symptoms of DB have similarities with other conditions 






















Table 2.1 Summary of the conditions that share symptoms with DB 
 
 HVS  
(Gardner, 1996) 
EIB  
(Hallstrand et al., 2013) 
EILO 






¥! Chest tightness 
¥! Dizziness 
¥! Light-headedness 
¥! Tingling sensation 





¥! Chest tightness 






¥! Chest tightness 
¥! Throat tightness 
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chemical changes (e.g.  
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Release of inflammatory 
mediators, along with 
airway dehydration, 
cause an exaggerated 






involvement, due to 
abnormalities of the 
epiglottis, the 
laryngeal cartilage-
skeleton or its support, 
mucosal structures, 






and panic disorder) 
have been proposed to 











(1) Vigorous exercise 
challenge test  
(2) Eucapnic voluntary 
hyperpnoea (EVH) 
challenge test 









Due to the diversity of symptoms and clinical signs, patients with cardio-respiratory 
symptoms often undergo several investigations with negative results and remain 
undiagnosed (Jones et al., 2013). When screening for DB, it has been recommended to 
include biochemical measures (e.g. end tidal carbon dioxide (ETCO2)), biomechanical 
measures (e.g. the evaluation of breathing pattern) and psychological features (e.g. the 
assessment of anxiety) as DB is proposed to have dimensions related to those functions 
of breathing (Courtney et al., 2011a, van Dixhoorn J, Folgering H., 2015). Respiratory 
symptoms and respiratory function should also be considered (Courtney et al., 2011a). 
All of the key diagnostic tests will be discussed in greater detail in Chapter 2.3.4 with 
regards to their clinical adequacy and limitations.  
 
It is important to investigate whether DB occurs alone or in conjunction with other 
respiratory disorders, hence appropriate information and treatment can be provided. A 
clear link between DB and other respiratory diseases has not yet been described in the 
literature, however clinical studies suggest that a DB pattern does occur in patients with 
e.g. chronic obstructive pulmonary disease (COPD) and interstitial lung disease 
(Boulding et al., 2016). Nevertheless, the most widely recognised form of DB is HVS, 
which was first described over 70 years ago (Boulding et al., 2016, Kerr et al., 1938). 
This term is often also used synonymously with DB, whereas in fact it should be 
considered as a separate entity.  
 
2.3.3.1 Hyperventilation syndrome (HVS) 
 
Hyperventilation occurs when the rate and quantity of alveolar ventilation of carbon 
dioxide (CO2) exceeds the bodyÕs metabolic requirements (i.e. CO2 production) (Gardner, 
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1996) and results in hypocapnia. Hyperventilation is associated with an abnormality in 
respiratory control and may present with symptoms such as breathlessness, frequent 
sighing, dizziness, paraesthesia and palpitations (Kerr et al., 1938). The term 
Òhyperventilation syndromeÓ was first used by Kerr et al. (1938) to describe patients with 
somatic symptoms of both hypocapnia and anxiety and the prevalence has previously 
been estimated to 6 - 10% (Lum, 1975). 
 
Nevertheless, some symptoms associated with HVS have been shown to be unrelated to 
hypocapnia and may be due to other, rather psychological than physiological mechanisms 
(Courtney et al., 2011a, Howell, 1997, Hornsveld et al., 1996). Athletes, especially at 
elite levels, are typically exposed to a variety of stressors both in training and competition 
contexts and this might be the reason why they frequently experience symptoms of 
hyperventilation. High level athletes invest considerable time and effort in their sport and 
their performance may have profound consequences on their future career and life 
(Gustafsson et al., 2016, Conroy et al., 2001). As such, competitive athletes may perceive 
certain situations as threatening, challenging, or stressful (e.g., defeat, performance 
slumps, performing in a crucial competition) (Gustafsson et al., 2016), they often 
experience stress due to the pressure and challenges to win and progress (Conroy et al., 
2007, Sagar et al., 2007, Sagar et al., 2010). Previous research has shown that fear of 
failure is related to anxiety and that psychological stress together with athletes 
Òmaladaptive coping responses to their fear of failureÓ might pose a risk of burnout 
(Gustafsson et al., 2016). It has also been proposed that high fear of failure is not only 
problematic when the athletes are young, but its impact can increase as the athletes get 
older (Conroy, 2001).  
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The term HVS has been used in so many different settings that its usefulness is questioned 
(Gardner, 1996). In a sport setting for example, the previously mentioned psychological 
factors can manifest hyperventilation as a symptom, however, it can also be an indirect 
response to the metabolic demands of exercise and therefore should not necessarily be 
considered as an abnormality. 
 
2.3.3.1.1. Assessment for HVS 
 
Hyperventilation syndrome can be assessed by a routine procedure called the 
hyperventilation provocation test (HVPT). The HVPT requires patients to voluntarily 
overbreathe for several minutes and is considered positive, if symptoms of HVS were 
reproducible (Boulding et al., 2016). Although it was previously assumed that HVPT, by 
inducing hypocapnia, reproduce hyperventilation symptoms, Hornsveld et al. (1996) 
showed that the mechanisms of most symptoms do not require a fall in PCO2 and the 
attacks does not need to be associated with hypocapnia. These findings make the 
reliability of HVPT questionable.  
 
2.3.3.2 Exercise-induced bronchoconstriction (EIB) 
 
Exercise-induced bronchoconstriction is defined as a heterogeneous condition, usually 
characterised by a transient narrowing of the airways (Figure 2.1) that occurs in 
association with exercise and is reversible spontaneously or through the inhalation of β2-













Figure 2.1 Anatomy of exercise-induced bronchoconstriction 
Retrieved from: http://www.clivir.com/pictures/asthma/asthma_attack.jpg 
 
Exercise induced bronchoconstriction has been estimated to occur in about 80-90% of 
asthmatics (Molphy et al., 2014). Respiratory symptoms and EIB are now recognised to 
be highly prevalent in certain groups of elite athletes (Price et al., 2013). Indeed, a greater 
prevalence of asthma related conditions has been reported in elite Great British athletes 
(21%) (Dickinson et al., 2005) when compared to the United Kingdom (UK) general 
population (approximately 10%) (National Asthma Campaign, 2001). This heightened 
prevalence of EIB in elite athletes (Dickinson et al., 2006, Dickinson et al., 2011) is 
thought to arise principally due to a combination of the deleterious impact of certain 
environmental exposures (e.g. pollution, swimming pool chemicals) and high ventilatory 
requirements necessitated by elite level sport (Dickinson et al., 2006, Bougault et al., 
2009, Bougault & Boulet, 2012). Numerous studies have established a high prevalence 
of EIB in certain Ôhigh-riskÕ sports, e.g. elite level swimming (41% - 55%) (Dickinson et 
al., 2005, Castricum et al., 2010). 
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The pathophysiology of EIB is not entirely understood, but it has been suggested that 
during strenuous exercise, hyperventilation and humidifying large volumes of 
unconditioned air to body temperature over a short period of time, causes a loss of heat 
(Anderson & Kippelen, 2005) and drying of the airways, leading to dehydration of the 
airway surface liquid (ASL) (Molis & Molis, 2010). Once the exercise is completed and 
ventilation returns to normal, airway cooling reverses as smaller bronchial vessels warm, 
creating a reactive hyperaemia (Anderson & Kippelen, 2005). This process triggers a 
cascade of events that includes (1) an increase in intracellular osmolarity, (2) initial water 
movement from the surrounding cells toward the airway lumen, (3) the shrinkage of 
subepithelial cells and (4) the release of bronchoconstrictive inflammatory mediators, 
including histamines, cytokines, and leukotrienes, among others (Hallstrand et al., 2013). 
These mediators, along with airway dehydration, cause an exaggerated response that 
results in bronchial smooth muscle contraction and consequently EIB (Hallstrand et al., 
2013).  
 
The water loss occurring at high ventilatory rates increases risk of airway inflammation 
and epithelial injury (Anderson & Kippelen, 2005). In the presence of allergenic stimulus, 
the repair mechanisms of the epithelium activate the airway smooth muscle, lead to 
alteration of their contractile properties causing hypersensitivity that can sustain a 
propensity to bronchoprovocation either during or following exercise (Anderson & 
Kippelen, 2008). A proposed mechanism underlying the relative high prevalence of EIB 
in athletes suggests repeated exposure to airborne irritants and sensitising agents (e.g. 
halocetic acids and trihalomethanes) that float just above the water surface can induce 
airway inflammation, smooth muscle hyperresponsiveness and remodelling processes 
that may lead to the development of asthma related conditions such as EIB (Bougault et 
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al., 2009, Bougault & Boulet, 2012). 
 
Due to the similarities in symptoms, it is not uncommon that patients with DB are 
misdiagnosed and prescribed asthma medication unnecessarily (Lowhagen, 2005, 
Lowhagen, 1989, Marklund et al., 1999). It has been claimed by Ansley et al. (2012)  that 
only half of the professional soccer players with a physician diagnosis of asthma/EIB had 
objective evidence of reversible bronchoconstriction. Rundell et al. (2001) demonstrated 
no association between the reporting of wheeze during usual training and the bronchial 
response to a sport/environment-specific field exercise challenge test; in approximately 
half of the athletes EIB did not explain the occurrence of symptoms. This underlines the 
importance of an objective bronchial challenge test to support a symptoms-based 
diagnosis of EIB in athletes prior to commencing pharmacological treatment. 
 
2.3.3.2.1. Assessment for EIB 
 
The assessment of EIB in athletes requires serial lung function measurements (e.g. FEV1, 
FVC) before and after (1) vigorous exercise challenge test or a surrogate of exercise such 
as (2) eucapnic voluntary hyperpnoea (EVH) challenge or (3) mannitol dry powder 
test (Parsons et al., 2013, Anderson & Kippelen, 2012). 
 
(1) The exercise challenge test involves a rapid increase in exercise intensity over about 
2 to 4 minutes to achieve a high level of ventilation (for athletes V̇E must be > 25 times 
the FEV1) continued by exercise at that high level for an additional 4 to 6 minutes.  
Measurements of FEV1
 
are made usually in duplicate at 3, 5, 10, 15, 20 and 30 minutes 
post exercise, and the higher of the two values is recorded. The criterion to diagnose EIB 
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using this assessment method is ≥ 10% fall in FEV1 (Anderson & Kippelen, 2012). 
 
When conducting on the field, monitoring the conditions (e.g. temperature, humidity) and 
having the right equipment available (e.g. spirometer, heart rate monitor) are challenging. 
In a laboratory setting, the greatest limitation is the wide variety of exercise protocols that 
are used, some of which are inadequate to provoke EIB. Due to the release of 
bronchodilation substances at low ventilation, exercise tests that start with a very low 
workload or uses a continuous increase in intensity for assessing maximum capacity may 
lead to false negative results (Anderson, 2011). Although a sports-specific exercise field 
test may simulate the exercise environment and demonstrate a reduction in airflow, due 
to its poor sensitivity for diagnosis and difficulty to perform reliably, this method of 
assessment has not been recommended as a first-line investigation in EIB (Dryden et al., 
2010). 
 
(2) Eucapnic voluntary hyperpnoea challenge is a 6-minute breathing test during which 
the individual inhales a dry gas containing, 21% O2, 5% CO2 and 74% nitrogen (N2) at a 
ventilation equivalent to 30 times FEV1
 
or more. After the test the lung function 
measurements are made at the same time interval as for exercise and a sustained ≥ 10% 
fall in FEV1 is considered a positive test. 
 
This assessment method is said to be a surrogate 
for exercise, since the ventilation achieved voluntarily is higher than that achieved during 
maximum exercise, thus the rate of false-negative results is very low (Anderson & 
Kippelen, 2012). 
 
(3) Dry powder mannitol inhalation increases the osmolarity of the airway surface and 
causes release of the same inflammatory mediators as exercise and EVH (Anderson & 
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Kippelen, 2012). The commercially available test kit contains pre-packed capsules 
containing 5, 10, 20 or 40 mg of mannitol and an inhaler device. The FEV1 is measured 
in duplicate 60 seconds after each dose. A 15% fall in FEV1 at ≤ 635 mg is considered a 
positive test result (Anderson & Kippelen, 2012). 
 
Diagnosing asthma correctly requires detailed knowledge of the range of symptoms and 
the possible underlying conditions. This, however, does not seem to be the current 
practise. Some studies indicate that as many as one third of those with a diagnosis of 
asthma in developed countries do not actually have asthma (Marklund et al., 1999) and 
since there exist no validated protocols to confirm or exclude the condition in patients 
with previous physician diagnosis (that may or may not have been accurate), these 
patients may retain their Òasthmatic statusÓ for long years or in some cases for a lifetime  
(Luks et al., 2010). Inhaled corticosteroids (ICS), when properly used, improve quality 
of life and reduce the risk of asthma attacks and mortality. However, there is now 
evidence that they can cause mucosal immunosuppression and an increased risk of 
respiratory infections in adults. Additionally, the systemic absorption of ICS, and 
therefore the risk of developing side effects, is greater if the dose is inappropriately high 
for the degree of airway inflammation (Bush & Fleming, 2016).  
 
On the other hand, a DB pattern such as dynamic hyperinflation without any 
bronchoconstriction has been proposed to be an important contributor to exaggerated 
dyspnoea in patients with asthma (Lougheed, 2007). Previous report (Marklund et al., 
1999) showed that about 10% of patients diagnosed as asthmatics actually suffer from a 
Òfunctional breathing disorderÓ, which in the lack of diagnostic strategies may remain 
unrecognised and untreated. 
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2.3.3.3 Exercise-induced laryngeal obstruction (EILO) 
 
Exercise-induced inspiratory symptoms (EIIS) may indicate an important differential 
diagnosis to EIB in otherwise healthy adolescents (Christopher & Morris, 2010, Roksund 
et al., 2009, Rundell & Spiering, 2003, Johansson et al., 2015). EIIS is most often linked 
to laryngeal abnormalities (Christopher & Morris, 2010, Roksund et al., 2009, Beaty et 
al., 1999, Bent III et al., 1996, Bittleman et al., 1994, Christensen et al., 2011, Dion et al., 
2012) and if so, referred to as EILO (Dion et al., 2012, Hull et al., 2014, Christensen et 
al., 2015). Studies of athletes (Kenn & Balkissoon, 2011, Christensen et al., 2011) and of 
soldiers (Morris et al., 1999) in stressful situations have revealed high rates of EIIS. The 
magnitude of EILO has been addressed and objectivised in different ways, and the 
estimates therefore vary; however, in unselected populations EILO has been reported in 
6 - 8% of adolescents (Johansson et al., 2015, Christensen et al., 2011). 
 
Underlying mechanisms remain unclear, and a variety of structural and/or functional 
pathways have been proposed, such as abnormalities related to the epiglottis, the 
laryngeal cartilage-skeleton or its support, mucosal structures as well as the laryngeal 
muscular system or its nerve supply (R¿ksund et al., 2016, Maat et al., 2011). All these 
abnormalities might conceivably disturb the airflow on its way through the laryngeal 
inlet, increase the turbulence and the airflow resistance, and thereby set up a sense of 
dyspnoea and trigger the symptoms that are characteristic of EIIS (Templer et al., 1991).  
Additionally, various psychological characteristics (e.g. anxiety, depression and panic 
disorder) have been proposed to be implicated in this causal cascade (Maat et al., 2011) 
by triggering sufficient narrowing of the laryngeal space to cause breathing difficulties 
and a laryngoscopic image compatible with laryngeal obstruction to airflow.  
 24 
EILO may be caused by adduction or collapse of supraglottic structures, inappropriate 
closure of the glottis, or a combination of these events (R¿ksund et al., 2016) (Figure 2.2). 
A validated grading scheme developed for the diagnosis of EILO has been used to assess 
obstruction both at the glottic and supraglottic level, and differentiates between 
obstructions occurring at moderate and maximal effort (Maat, 2011). 
 
 
Figure 2.2 Glottic and supraglottic exercise-induced laryngeal obstruction 
(Hall et al., 2016) Retrieved from: http://bjgp.org/content/66/650/e683/tab-figures-data 
 
 
2.3.3.3.1 Assessment for EILO 
 
The gold standard diagnostic test for EILO is called the continuous laryngoscopy exercise 





Figure 2.3 Continuous laryngoscopy exercise (CLE) test 
(Hall et al., 2016) Retrieved from: http://bjgp.org/content/66/650/e683/tab-figures-data 
 
 
This technique combines a full cardio-respiratory treadmill exercise set-up and uses 
flexible naso-endoscopy to provide a continuous image recording of the larynx 
throughout an exercise to the maximum, thereby enabling a dynamic recording of the 
movement of the laryngeal structures from start to stop. A camera and a microphone 
placed in front of the subject enable recording of simultaneous video images of the 
external upper part of the body as well as recordings of the respiratory sounds. The 
participant runs on a treadmill according to a standardised protocol, incrementing speed 
and/or grade every minute with the aim to obtain peak oxygen consumption (V̇O2 peak) 
after 6 - 12 min of exercise. The test is considered completed, if the patient experience 
respiratory complaints, or indicate exhaustion, preferably supported by a plateau in 
oxygen consumption (V̇O2) and/or the heart rate (HR). All recordings continue until 
breathing returns to normal resting values (Heimdal et al., 2006). 
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Previous reports have concluded that EILO is more prevalent in young females when 
compared to males (Bjrnsdttir et al., 2000, Smith et al., 1995, Gardner, 1996); Morris 
et al. (1999) reported a 2:1, whilst Brugman et al. (2003) found a 3:1 female 
predominance among their patients. One potential explanation of this is the difference in 
structural characteristics of the larynx between genders. According to observations from 
anatomical studies, the laryngeal inlet does not show significant gender differences when 
evaluated in pre-puberty, however considerable divergence in larynx dimensions occur 
during the development period (Maat, 2011). As such, in post-puberty Òthe male larynx 
enlarges considerably in comparison with that of the female; all the cartilages increase in 
both size and weight, the thyroid cartilage projects in the anterior midline of the neck, 
and its sagittal diameter nearly doublesÓ (Standring, 2015).  
 
2.3.4 Assessment for DB 
 
2.3.4.1 Nijmegen Questionnaire (NQ) 
 
The most common method of diagnosing DB relies on a positive NQ (Boulding et al., 
2016). The NQ was developed over 30 years ago as a screening tool to detect patients 
with hyperventilation complaints that could benefit from breathing regulation 
interventions (van Dixhoorn J, Folgering H., 2015). Although the NQ was developed and 
validated only in people with HVS, since the 1970s it has been used to identify and 
characterise DB in the general population (Courtney et al., 2011b), those with anxiety 
disorders (van Dixhoorn & Duivenvoorden, 1985) and patients with co-existing 
respiratory diseases e.g. asthma (Thomas et al., 2001, Thomas et al., 2003, 
Grammatopoulou et al., 2014). This self-completion questionnaire, developed by a group 
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in the Netherlands, comprises 16 items, that include symptoms common to both anxiety 
and asthma and related to different systems, such as cardiovascular, neurological, 
respiratory, gastro-intestinal, but also linked to psychological factors. For each of the 16 
items, experience of the given symptom has to be rated on a five-point ordinal scale 
(where 0 is never and 4 is very often) (van Dixhoorn & Duivenvoorden, 1985). The NQ 
was shown to have a sensitivity of 91% and specificity of 95% in relation to the clinical 
diagnosis of HVS (van Dixhoorn & Duivenvoorden, 1985). A score of 23/64 or higher 
has been considered positive and suggestive of DB (van Dixhoorn & Duivenvoorden, 
1985), although, in the validation study, this was calculated using a positive 
hyperventilation provocation test as the gold standard, which itself is no longer 
considered a reliable way of diagnosing HVS (Hornsveld et al., 1996).  
 
The NQ has recently been validated in asthma patients. In this specific population the 
approximate prevalence of HVS was found to be 34% (Grammatopoulou et al., 2014). As 
many of the symptoms described in the NQ will occur in asthma the true prevalence of 
HVS in asthmatics is likely to be overestimated (Boulding et al., 2016). It has been 
previously reported by Demeter et al. (1986) that up to 80% of patients diagnosed with 
HVS may in fact have an underlying diagnosis of asthma (Demeter & Cordasco, 1986). 
Asthmatics with HVS tend to be female, have poor asthma control, frequent exacerbations 
and comorbid anxiety states (Agache et al., 2012).  
 
2.3.4.2 Self-Evaluation of Breathing Questionnaire (SEBQ)  
 
The SEBQ is a recently developed questionnaire that is aimed to evaluate the quality and 
quantity of uncomfortable respiratory sensations and the perception of breathing 
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(Chaitow et al., 2014d). It contains 25 items to be answered on a 3-point scale, ranging 
from never (counted as zero) to very frequently (counted as 3). Factor analysis showed 
that SEBQ can differentiate two distinct categories or dimensions commonly reported by 
patients with DB: the feeling of Òlack of airÓ and the perception of Òrestricted breathingÓ 
(Courtney & Greenwood, 2009). The two dimensions were said to represent both 
biomechanical and biochemical mechanisms and also sensory and cognitive aspects of 
interoception (Chaitow et al., 2014d) contributing to DB, which have often been 
implicated in other studies (Harver et al., 2000). Research to establish normative values 
for the SEBQ has not been formally undertaken, however Courtney et al. (2011a) reported 
that individuals with NQ scores below 20 had a mean score of 11 for the SEBQ.  
 
2.3.4.3 End-tidal capnography 
 
End-tidal capnography is the non-invasive measurement of exhaled CO2. Capnography 
measures average CO2 partial pressure at the end of exhalation, known as end-tidal carbon 
dioxide (ETCO2) and has good concurrent validity when compared to arterial CO2 
measures (Bradley & Esformes, 2014). Normal ranges were claimed between 35 -	40 
mmHg, while values of < 35 mmHg were suggestive of HVS (Levitzky, 2003). 
Capnography can be used in endurance athletes whilst exercising on a bike or treadmill 
to isolate the anaerobic threshold. Feedback on the carbon-dioxide production (V̇CO2) 
can help athletes to recognise the signs of anaerobic metabolism (Chaitow et al., 2014b). 
When they are able to identify signs that suggest that anaerobic threshold is approaching, 
they can reduce their effort in order to prevent the threshold being crossed, allowing 
themselves to continue the exercise (Chaitow et al., 2014b). Study of Walsh et al. (2006) 
shows that athletes reach exhaustion 45 seconds sooner when they overbreathe before 
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exercising. Although capnography could potentially be used by athletes to make 
alterations to their respiration (e.g. breathing faster or slower, more or less volume) and 
by doing so reducing the effects of hyperventilation, it is not a useful diagnostic tool when 
the symptoms are triggered by inefficient breathing pattern, as seen in DB. 
 
2.3.4.4 Depth and rate of breathing 
 
Both depth and frequency of breathing are adjustable, independently from each other, 
depending on the bodyÕs metabolic need for air (Chaitow et al., 2014c). The combination 
of breathing volume and frequency is calculated by the brain to adjust air exchange. A 
mismatch of these variables due to abnormal control or execution of breathing, leads to 
altered V̇E and consequently homeostatic imbalance (Chaitow et al., 2014c). 
 
Compared to increasing frequency, increasing the depth of respiration is more effective 
for enhancing alveolar ventilation, but only to a certain extent. Increasing the depth of a 
breath is resisted by the elastic forces, which bring about exhalation; breathing faster is 
opposed by the friction of ventilating the airways (Chaitow et al., 2014c). Due to CO2 
deficiency, both increased frequency (Folgering, 1999) and increased breathing depth 
(Courtney & Cohen, 2008) cause respiratory alkalosis, that reduce cerebral circulation 
and interfere with neuro transmission resulting in confusion and dizziness (Gilbert, 1998). 
 
The regularity or stability of the breathing cycle may reflect changes in appraisal of 
external demands as well as inner distractions and associations, therefore assessing these 
parameters may be beneficial in the evaluation of DB. Several assessments are available 
to practitioners to carry out these assessments. 
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2.3.4.5 Breath holding time (BHT) 
 
Breath holding time is an indicator of an individualÕs ventilatory response to biochemical, 
biomechanical and psychological factors (Delapille et al., 2001). The precise mechanisms 
explaining breath-holding and causing the breath at breakpoint are unknown (Parkes, 
2006). Some life situations (e.g. uncertainty about what action to take next, or waiting a 
moment for more information) are reflected in the breathing, as the brain switches 
between action preparation, focused attention and suppression (Chaitow et al., 2014d). 
When precise sensory attention is needed or when attempting to remain undetectable, the 
breathing may be suspended for a few seconds. If breathing is reduced or stopped for a 
short period, O2 reserve slowly declines and there is an increase in CO2 levels, which 
stimulates more breathing. This process lowers the increased CO2 levels and the cycle 
starts over again (Chaitow et al., 2014d). While no standardised test yet exists, breath-
hold times are recorded by many clinicians as part of HVS assessment. A shortened BHT 
may indicate abnormalities in respiratory control (Lin et al., 1974), and is commonly 
observed in individuals with inclinations towards hyperventilation and/or DB (Warburton 
& Jack, 2006).  
 
Breath-holding time differs significantly depending on how and under what experimental 
conditions it is performed. It is affected by whether the hold occurs after inhalation or 
exhalation, but also depends on the initial lung volume. The most commonly used method 
for evaluating and monitoring DB is the Buteyko method that includes a post-expiratory 
breath hold (a.k.a. BHT control pause) at tidal volumes. It is performed either by holding 
the breath until the first urge to breathe or until the first involuntary motion of the 
respiratory muscles (Courtney & Cohen, 2008). Using this method, a short BHT (< 20 
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seconds) is considered an indicator of DB (Boulding et al., 2016, Gardner, 1996), 
however results should be interpreted with caution as breath-holds produce discomfort, 
which is not tolerated by all individuals the same way. Also, it is difficult to tell if the 
individuals tried equally hard to perform the assessment, therefore defining a cut off value 
is challenging. Although breath-holding ability reflects on breathing functionality, due to 
the number of limitations of the test, this assessment method was not used in this thesis. 
 
2.3.4.6 Manual assessment of respiratory motion (MARM)  
 
Manual assessment of respiratory motion is a tool used for assessing and quantifying the 
relative distribution of breathing motion between the upper and lower rib cage and 
abdomen (Boulding et al., 2016). The MARM is a palpatory procedure based on the 
examiners interpretation and estimation of motion perceived by their hands at the 











Figure 2.4 Performing the MARM (Chaitow et al., 2014e) 
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Although MARM has been shown to be a cost-efficient and easily applicable tool to 
assess breathing abnormalities with a good inter-examiner reliability as compared to 
plethysmography (Courtney et al., 2008), the assessment is limited to a still state and 
therefore its application in a sport setting is not feasible. 
 
2.3.4.7 Respiratory induction plethysmography (RIP)  
 
Respiratory induction plethysmography has been used as a tool to monitor ventilation and 
breathing patterns in multiple settings (e.g. in sleep studies or in critical care) (Brullmann 
et al., 2010). In this non-invasive respiratory monitoring method, the user wears an elastic 
band with inductance coils across the chest and abdomen to measure changes in 
respiratory excursion of the rib cage and abdomen during respiration (Figure 2.5) in order 
to distinguish between abdominal and thoracic breathing and to determine a Òphase angleÓ 
(the relationship between chest and abdominal movements) as a measurement of 
asynchrony (Courtney et al., 2008). For movements that are perfectly synchronous (in 
phase), phase angle = 0¡; for completely asynchronous (out-of-phase) movements phase 
angle = 180¡ (Brullmann et al., 2010). 
 
 
Figure 2.5 Respiratory induction plethysmography: principle of measurement 
Retrieved from: https://glneurotech.com/images/bioradio/wireless-resp-banner.jpg 
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Although RIP is a widely deployed method for non-invasive respiratory monitoring in 
adults, it has two major limitations: (1) its working principle is inherently sensitive to 
metallic or magnetic materials in the near surrounding of the subject and (2) for accurate 
recording that is free from motion artefacts, individuals are required to stay still during 
the assessment. The optimal conditions needed for the assessment are impossible to 
achieve in a laboratory, where athletes are tested during exercise and are surrounded by 
metal-containing devices (e.g. ergometer). 
 
2.3.4.8 Structured light plethysmography (SLP) 
 
Structured light plethysmography uses a visible or infra-red (IR) grid of light that is 
projected onto the chest and abdomen, allowing respiratory movements to be tracked or 
visualised by a digital camera system and respiratory data to be derived (Levai et al., 











Figure 2.6 Structured light plethysmography: principle of measurement 
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Although this technology has a great advantage of allowing to measure ventilatory 
parameters in those whom conventional spirometry is difficult to perform (e.g. elderly 
people, children, immobile or surgical patients), it also has major limitations: (1) The 
projected grid is divided into equal portions by a blue cross in the middle, which allows 
the image to separate the chest and abdominal movements. Anatomically, the length of 
the chest and abdomen varies in every person, regardless of gender, age etc. and therefore 
projecting the grid to cover the torso from top to bottom will provide an unrealistic picture 
of the chest and abdomen contributions. (2) To ensure the grid is projected clearly, 
subjects need to wear a tight-fitting white T-shirt. If the T-shirt is not tight enough, 
particularly at the bottom, that causes creases and wrinkles on the T-shirt, which can 
affect the quality of the projection. Similarly, another problem occurs with regards to 
female subjects who have different body composition from men; lumps and bumps 
around the abdominal area and/or large breasts also affect the grid projections. (3) In the 
lack of fixed marker points (on shoulders, hip bone etc.), it is not possible to accurately 
project and position the exact same grid on a subject at different time points, hence the 
SLP measurements repeatability is questionable. (4) Some athletes may have breathing 
problems due to their posture/shoulder positioning and therefore it would be necessary to 
measure the upper part of their chest. However, it is not possible to cover the shoulder 
area with the grid during measurements, as this would result in the grid projection being 
lost to the side causing the overall results to be distorted. Also, due to some technical 
limitations an upward shoulder movement, which would be essential to be detected, will 
not appear in the 3D reconstruction. (5) As the device is very sensitive, any movement of 




2.3.4.9 Optoelectronic plethysmography (OEP)  
 
Optoelectronic plethysmography is an innovative method of indirect measurement of 
pulmonary ventilation, capable of three-dimensional, real-time assessment of absolute 
lung volumes and their variations across the pulmonary ribcage, abdominal rib cage and 
abdomen (Parreira et al., 2012). It uses an optical reflectance motion analysis by 
computing the 3D coordinates of physical markers fixed on the chest and abdomen of the 












Figure 2.7 Optoelectronic plethysmography: principle of measurement (Vogiatzis 
et al., 2005) 
 
Optoelectronic plethysmography has been shown to be a valuable and accurate 
assessment tool that can provide crucial information about chest wall mechanics 
including the measurement of variables of breathing pattern, breathing asynchrony, and 
contribution of each chest wall compartment and hemithorax to the tidal volume (Parreira 
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et al., 2012). Although OEP is able to measure volume variations with high accuracy and 
validity in different populations and experimental protocols, currently research is limited 
to healthy subjects and respiratory diseases such as COPD (Massaroni et al., 2017). 
 
The large number (89 - 90) of markers used for the OEP assessment makes its 
employment in the daily clinical practice as an alternative tool for traditional flow-based 
instrument to assess respiratory parameters, very much challenging (Massaroni et al., 
2017). In fact, the markers placement is time-consuming and in some cases complicated 
(e.g. in individuals in which the landmarks are difficult to identify). Moreover, at the 
moment the cost of an eight-cameras system OEP is very high.  
 
Despite these limitations, OEP has several advantages. Compared to the previously 
mentioned assessment methods, OEP has the ability to simultaneously assess respiratory 
volumes and the biomechanical components of breathing (Massaroni et al., 2017). Special 
algorithms allow to obtain volume variations not only of the whole chest wall, but of the 
different compartments. It provides a better comprehension of the work of breathing 
without interventions using invasive instrumentation (Massaroni et al., 2017). 
Additionally, OEP is able to measure breathing patterns in any condition (at rest and 
during exercise) and it can be used to study respiratory kinematics and, if combined with 
pressure measurements, statics, dynamics and energetics. The use of this technology has 
its great potential in assessing breathing patterns in respiratory conditions that are difficult 
to diagnose objectively and therefore was the chosen assessment method to investigate 






Perceived exertional dyspnoea is reported to be the most common symptom, limiting 
performance and/or enjoyment of sporting activities among athletic individuals of all 
abilities and ages. Indeed, some describe the sensation of exercise breathlessness as the 
main barrier to participation in physical activity and/or high performance sport. 
 
Exercise-respiratory symptoms such as cough, wheeze and chest tightness are not 
exclusive to only one condition; they can be associated with EIB, EILO and DB. 
Identifying and clarifying the cause of the perceived symptoms require careful assessment 
with a wide range of factors potentially contributing to the reported symptoms. In groups 
of elite athletes, estimates of rate of incorrect diagnosis of EIB have ranged between 20 - 
50% (Ansley et al., 2012). The use of indirect airway challenges helps to reduce the 
chance of incorrect diagnosis, but research investigating the causes of exercise respiratory 
symptoms other than EIB is very limited.  
 
Dysfunctional breathing is a term describing a group of breathing disorders, where 
chronic changes in breathing pattern result in dyspnoea and often non-respiratory 
symptoms in the absence, or in excess of, organic respiratory disease. Although accurate 
identification of the causative factors contributing to the exercise-respiratory symptoms 
is critical in order to ensure that optimum care is delivered to this specific population, in 
the lack of well-established differential diagnostic tools, healthcare professionals and 
team physicians face with a major challenge when attempting to distinguish among the 
perception of symptoms that may occur as a physiological response to exercise, those 
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indicating underlying cardiorespiratory pathology and/or complaints that are non-organic 
of origin. 
 
Despite of its urgent need in clinical practice, several aspects of exercise respiratory 
problems in physically active individuals, such as effects of body position on respiratory 
performance and breathing pattern, remain unclear or have not been acknowledged in 
previous research. Therefore, the aim of this present thesis is to explore the identified 
gaps in the literature and investigate possible assessment methods that would assist 
practitioners in identifying and differentiating between pathological and non-pathological 
causes and contributing factors of breathing dysfunction.  
 
Specifically, investigations will be undertaken in order to explore whether environmental 
factors would affect the prevalence of airway dysfunction in high level sports and if the 
Nijmegen questionnaire is sensitive enough to distinguish between EIB and DB in an 
athletic population. It will also aim to study the possible physiological and/or 
biomechanical changes associated with altered shoulder positioning during exercise. 
Attempts will be made to investigate whether breath-by-breath analysis techniques and 
optoelectronic plethysmography have the ability to assess the suspected changes.  
 
2.5 Thesis aims and hypotheses 
 
The overall purpose of this thesis was to investigate different assessment approaches for 
identifying DB in athletes. The following chapters presents a series of studies, which 
contribute to the overall aim of the thesis. The aims and hypotheses of each experimental 
chapter are as follows: 
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Chapter 4 - ENVIRONMENTAL INFLUENCE IN THE PREVALENCE AND PATTERN 
OF AIRWAY DYSFUNCTION IN ELITE ATHLETES 
 
The aim of the chapter was to provide an Ôup-to-dateÕ evaluation of the prevalence of EIB 
in the Great British (GB) elite swimming squad but also, for the first time, to establish 
the prevalence of EIB in a cohort of screened elite-level boxers. A secondary aim was to 
compare the EVH challenge response and baseline fraction of exhaled nitric oxide 
(FeNO), as a surrogate of airway inflammation, between two sports with similar peak 
ventilatory demands, but with differing training environments. 
 
H1 Athletes who train and compete at a sustained high ventilation in environments that 
are provocative for the airways (and carry the risk of triggering airway inflammation) 
have an increased susceptibility to airway dysfunction defined by higher baseline FeNO 
concentrations and greater reduction in lung function following an EVH challenge.  
 
Chapter 5 - PREVALENCE OF DYSFUNCTIONAL BREATHING (DB) AND ITS 
RELATIONSHIP WITH AIRWAY DYSFUNCTION IN ATHLETIC INDIVIDUALS 
 
The purpose of this study was to investigate the prevalence of NQ positive responses in 
a cohort of physically active, young adults. A secondary aim was to directly compare 
whether an NQ score was related to the outcome of an objective testing for EIB (EVH 
testing).  
 
H1 In a physically active, young adult population, the prevalence of NQ positive 
responses is higher compared to reports of DB in non-athletic populations.  
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H2 There exists a poor relationship between the presence of symptoms on NQ and a 
diagnosis of EIB. 
 
Chapter 6 - THE IMPACT OF UPPER THORACIC POSTURE ON RESPIRATORY 
PERFORMANCE AND SYMPTOMS DURING EXERCISE 
 
The aim of this study was to investigate the effects of altered shoulder position on 
respiratory function and ratings of perceived exertion (RPE) and dyspnoea during high 
intensity exercise.  
 
H1 Cycling with hunched shoulders at high intensities over a prolonged period leads to 
altered breathing mechanics and as a consequence, an increase in perceived exertion and 
dyspnoea.  
 
Chapter 7 - OPTOELECTRONIC PLETHYSMOGRAPHY (OEP) IN THE ASSESSMENT 
OF DYSFUNCTIONAL BREATHING (DB) IN ATHLETES 
 
The aim of this study was to investigate the effect of different postural positions on the 
respiratory system using OEP in conjunction with a spirometer and a breath-by-breath 
(BbB) analyser. 
 
H1 Hunched shoulder position leads to increased abdominal motion to vital capacity and 




Chapter 3. Respiratory assessment tests used in 
the thesis 
 42 
In this current chapter, the respiratory assessment tests that were used for every 
experimental studies in this thesis will be discussed. The actual, extended method for each 
experiment can be find in the methodology section of each study chapter. 
 
3.1 Spirometry  
 
Spirometry is a medical test that measures the volume of air an individual inhales or 
exhales as a function of time (Miller et al., 2005). In the following collection of studies 
forced vital capacity (FVC) manoeuvres were performed exclusively. FVC is the 
maximal volume of air exhaled with maximally forced effort from a maximal inspiration 
(Miller et al., 2005). It is an effort dependent manoeuvre that requires cooperation 
between the test subject and the examiner, coordination and understanding by the 
participant. The American Thoracic Society (ATS) and the European Respiratory Society 
(ERS) has published guidelines for the measurement of lung function (Miller et al., 2005), 




Throughout the studies maximal flow volume loops were collected using either of the 
following turbine spirometers: SpiroUSBTM (Carefusion 234 Germany GmbH) or 
MicroLab¨ Spirometer (Carefusion 234 Germany GmbH).  
 
When gas flows through a turbine flow meter it makes a vane turn; flow through the tube 
is proportional to the number of revolutions per unit of time: the higher the flow is, the 
faster the turbine rotates. An infrared detector detects the rate at which the light from the 
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infrared source is interrupted by the passing of the turbine (Chan, 2008). The volume of 
the air passing through the turbine is proportional to the total number of pulses generated 
and the flow is proportional to the frequency of the pulse generation (Newall et al., 2006).  
 
3.1.2 Verification of spirometer 
 
The volume accuracy of the spirometers was checked in accordance with ATS/ERS 
criteria (Miller et al., 2005) at least once for each day of testing and was repeated every 
4 hours of use. A 3 litres syringe was used for the verification, during which expiratory 
and inspiratory manoeuvres were performed. The 3 litres volume was injected at low (0 
- 0.9 litres/second), medium (1.6 - 4.5 litres/second) and high (7 - 12 litres/second) flow 
rates. The procedure was repeated three times at each flow rate and verification was 
accepted if the volume accuracy was within 3% at all flows. 
 
3.1.3 Measurement of Maximal Flow Volume Loop 
 
In preparation for the test, equipment safety was checked in accordance with 
manufacturerÕs instructions and guidelines of the Association for Respiratory Technology 
and Physiology (ARTP) and British Thoracic Society (BTS) (Hill & Winter, 2013). On 
the day of testing the equipment was checked for cleanliness and records of maintenance 
and was in working order. Prior to the test a clear and comprehensive description of the 
nature and purpose of the test was given to the participants who were able to ask questions 
about the testing procedure. All participants provided informed consent and completed a 
questionnaire that included questions about smoking habits, recent illness(es), past 
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medical history and medication use. Participants were assessed for contraindications 
(Table 3.1A and 3.1B) and allergies.  
 









¥ Active infection e.g. acid-fast bacillus (AFB) testing positive tuberculosis (TB) 
until treated for 2 weeks 
¥ Conditions that may be cause serious consequences if aggravated by forced 
expiration such as dissecting /unstable aortic aneurysm, current pneumothorax, 
recent surgery including ophthalmic, thoracic, abdominal or neurosurgery 
Relative 
¥ Suspected respiratory infection in the last 4 - 6 weeks 
¥ Recent pneumothorax 
¥ Any condition which may be aggravated by forced expiration  
− Haemoptysis of unknown origin 
− Unstable vascular status such as recent (within 4 - 6 weeks) myocardial 
infarction 
− Uncontrolled hypertension or pulmonary embolism 
− History of haemorrhagic event (stroke) 
− Recent thoracic-, abdominal-, eye- or neuro-surgery (within 6 weeks) 
¥ Cervical problems 
¥ Communication problems such as learning disability or confusion 
¥ Any other physical problem the patient may have that may be detrimental 
if/when performing spirometry 
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Table 3.1B Key contraindications of the EVH challenge  






Participants body mass in kilograms (with minimal clothing and without shoes) and 
height in centimetres (without shoes and head in Frankfort plane position) were measured 
and entered into the spirometer alongside other details such as date of birth, gender and 
ethnicity. Participants were seated in a stable chair and asked to remain in the seated 
position throughout the whole manoeuvre. Breathing manoeuvres were explained and 
demonstrated to the participants. They were then asked to assume the correct posture 
(Figure 3.1), attach nose clips and inhale completely and rapidly until their lungs were 




¥ Patients with known significant airway obstructions (FEV1 < 50% of predicted 
or FEV1 < 1.5 L) 
¥ Recent severe acute asthma 
¥ Recent myocardial infarct or stroke within 3 months 
¥ Uncontrolled hypertension 
¥ Known aortic aneurysm 
Relative 
¥ Patients with mild-moderate obstruction (FEV1 < 75% of predicted) 
¥ Spirometry-induced bronchoconstriction 
¥ Pregnancy 






Figure 3.1 Spirometry measurement 
 
 
Participant was instructed to place a mouthpiece in their mouth, seal lips around the 
mouthpiece and blow out as fast and far as possible until no more air could be expelled 
while maintaining an upright posture. When participants could not exhale out any more, 
they were asked to take a maximal breath in. Throughout the manoeuvres, the participants 
were given informative, fluent and encouraging instructions to ensure compliance with 
standardised methods (Miller et al., 2005). A minimum of three maximal flow-volume 
loops were recorded with a rest period of at least 30 seconds in between manoeuvres. Test 
repeatability (Table 3.2) was checked and if necessary more manoeuvres, up to a 
maximum of eight attempts, were performed. For each maximal flow-volume manoeuvre 
the following parameters were measured: forced expiratory volume in one second 
(FEV1); peak expiratory flow (PEF); forced vital capacity (FVC); FEV1:FVC ratio 
(FEV1/FVC) and forced expiratory time (FET). The best of three technically acceptable 
measurements of FEV1 and FVC were selected in accordance with the acceptability 
criteria laid down in Table 3.2.  
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Table 3.2 Criteria for acceptance of maximal flow-volume loops (Miller et al., 2005) 
 
Within-manoeuvre criteria Ð Individual spirograms are ÒacceptableÓ, if 
1. They are free from artefacts  
¥ Leak 
¥ Poorly co-ordinated start/finish of the test (early termination or cut-off) 
¥ Cough during the first second of exhalation  
¥ Inadequate and/or incomplete inhalation/exhalation 
¥ Sub-maximal effort 
¥ Obstructed mouthpiece (tongue, teeth, loose dentures) 
¥ Additional breath taken during manoeuvre 
¥ Glottis closure that influences the measurement 
2. They have good starts 
¥ Extrapolated volume < 5% of FVC or 0.15 L, whichever is greater 
3. They show satisfactory exhalation 
¥ Duration of ≥ 6 second or a plateau in the volume-time curve or 
¥ If the participant/patient cannot or should not continue to exhale 
 
Between-manoeuvre criteria  
1. After three acceptable spirograms have been obtained, researcher applies the 
following tests 
¥ The two largest values of FVC must be within 0.15 L of each other 
¥ The two largest values of FEV1 must be within 0.15 L of each other 
2. If both of these criteria are met, the test session may be concluded 
3. If both of these criteria are not met, researcher continues testing until 
¥ Both of the criteria are met with analysis of additional acceptable 
spirograms, or 
¥ A total of eight tests have been performed, or 
¥ The participant/patient cannot or should not continue 
4. Researcher saves as a minimum, the three satisfactory manoeuvres 
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Predicted normal values were calculated as described by the European Community for 
Coal and Steel (ECCS) (Quanjer et al., 1994). All used consumables were disposed 
immediately after testing and equipment was left clean and ready for subsequent use.  
 
3.2 Eucapnic voluntary hyperpnoea (EVH) challenge 
 
The EVH challenge is an indirect bronchoprovocation test, a surrogate for exercise to 
identify EIB in athletes and defence force recruits with normal lung function at rest 
(Anderson, 2011). Lung function was considered normal if the following conditions were 
met: FEV1/FVC ≥ 70% of Lower limit of normal (LNN), FVC ≥ 70% of LNN and the 
shape of the flow-volume curve indicated no airflow limitation (Pellegrino et al., 2005). 
 
3.2.1 Participant preparation for the EVH challenge  
 
Participants were required to withhold inhaled asthma medications prior to testing as 
indicated in Table 3.3.  
 
Table 3.3 Medications and their required withholding times before the EVH 
challenge (Parsons et al., 2012) 
 
 
Time to withhold 
medication 
Medication 
8 hours Inhaled short-acting β2-agonist (e.g. salbutamol, fenoterol, 
terbutaline) 
48 hours 
Inhaled long-acting β2-agonist (e.g. formoterol, salmeterol) 
96 hours 
Leukotriene antagonists (e.g. montelukast) 
 
Inhaled corticosteroids (e.g. beclomethasone, fluticasone) 
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Participants were instructed to avoid high intensity exercise within 4 hours of the 
challenge as this may induce a refractory period (Parsons et al., 2013) and exert a 
protective effect against EIB (Edmunds et al., 1978). Due to the bronchodilator effects of 
caffeine (Duffy & Phillips, 1991), participants were asked to avoid consumption of 
caffeine-containing beverages and foods such as tea, coffee, cola, energy drinks and 
chocolate 4 hours before testing. On the day of the assessment participants completed a 
questionnaire stating any other medication they were using and whether they were 
suffering from any illness or injury (Table 3.1A). If an athlete was suffering from an illness 
that may limit the results of the test, they were asked to return when they were well and 
fit to complete the test.  
 
3.2.2 Completing the EVH challenge 
 
Prior to starting the EVH challenge, participants completed a minimum of three maximal 
voluntary flow-volume loops with the best FEV1 being recorded as their baseline 
measurement. During the assessment (Figure 3.2) participants were asked to attain a target 
V̇E of 85% of their predicted maximal voluntary ventilation (MVV) rate for 6 minutes, 












Figure 3.2 Eucapnic voluntary hyperpnoea challenge 
 
Inspired air during the EVH challenge consisted of 21% O2, 5% CO2 and 74% N2 with 
inspired air temperature 19¡C, and humidity < 2%. Note the 5% CO2 concentration in gas 
to maintain eucapnia and prevent participant from the adverse effect of prolonged 
hyperventilation, such as dizziness and nausea. The gas was delivered to each participant 
through a mouthpiece attached to the EVH kit that contains a gas cylinder, a reservoir and 





Figure 3.3 Equipment used to perform the EVH test 
Gas cylinder (1), regulator (2), demand resuscitator 30-150 L/min (3) high pressure tubing (4), 
rotameter (5), three-way tap (6), Douglas bag (7), wide bore tubing (8), large low resistance 
low dead space two-way valve (9), gas meter (10). 
 
 
During the EVH challenge verbal feedback was provided to the participant in order to 
encourage them to meet their target V̇E. After completing the EVH challenge, maximal 
voluntary flow-volume loops were measured at 3, 5, 7, 10 and 15 minutes at each time 
points. Two flow-volume loops were collected and the maximal flow-volume loop with 
the highest FEV1 was recorded. The test was deemed positive, if the FEV1 fell by at least 
10% from baseline at two consecutive time points (Parsons et al., 2013). The severity of 
a positive EVH-challenge was graded as mild, moderate or severe if the percent fall in 
FEV1 from baseline values were ≥ 10% but < 25%, ≥ 25% but < 50% and ≥ 50%, 
respectively (Parsons et al., 2013). Following the bronchoprovocation challenge 
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participants were not allowed to leave the laboratory until their FEV1 was within 10% of 
their baseline FEV1. Those individuals, who had not returned to within 10% of FEV1 
within 15 minutes after stopping the challenge were offered 400 µg inhaled Salbutamol to 
assess their reversibility to bronchoconstriction. Spirometry was performed 15 minutes 
post-inhalation of Salbutamol (Miller et al., 2005). A positive bronchodilator response 
(reversibility) was defined as an increase of ≥ 12% and 200 ml in post-EVH FEV1 and/or 
FVC (Miller et al., 2005). Following the assessments, participants were given a detailed 
report of their respiratory health, and those who had a positive EVH challenge test were 
recommended to consult with their general practitioner (GP) or team doctor for further 
treatment.  
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Chapter 4. Environmental influence in the 
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4.1 Abstract  
 
Introduction: Elite swimming and boxing require athletes to achieve relatively high 
minute ventilation. The combination of a sustained high ventilation and provocative 
training environment may impact the susceptibility of athletes to EIB.   
Aims and objectives: The purpose of the study was to evaluate the prevalence of EIB in 
elite GB Boxers and Swimmers.   
Methods: Athletes from GB Boxing (N = 38, mean ± SD age:  22. ± 3 yr) and GB 
Swimming (N = 44, mean ± SD age: 21 ± 3 yr) volunteered. Athletes completed an 
exercise-induced respiratory symptoms questionnaire, baseline assessment of FeNO, 
maximal spirometry manoeuvres and an EVH challenge. EIB was confirmed, if FEV1 
reduced by ≥ 10% from baseline at two time points post-EVH challenge.  
Results: The prevalence of EIB was greater in elite swimmers (30 of 44; 68%) than 
boxers (3 of 38; 8%) (p < 0.001). Twenty-two out of the 33 (67%) EVH-positive athletes 
had no prior diagnosis of asthma/EIB. Moreover, 12% (6 of 49) of the EVH-negative 
athletes had a previous diagnosis (Dx) of asthma/EIB. We found a correlation between 
FeNO and FEV1 change in lung function post-EVH challenge in swimmers (r = 0.32; p = 
0.04), but not in boxers (r = 0.24; p = 0.15). 
Conclusion: The prevalence of EIB was nine fold greater in swimmers when compared 
with boxers. Athletes who train and compete in provocative environments at sustained 
high ventilation may have an increased susceptibility to EIB. It is not entirely clear 
whether increased susceptibility to EIB affects elite sporting performance and long-term 






Exercise-induced bronchoconstriction has been shown to be highly prevalent in certain 
groups of elite athletes (e.g. swimmers, cyclists, cross country skiers) (Dickinson et al., 
2006, Dickinson et al., 2011, Fitch, 2012). It has been previously reported by Dickinson 
et al. (2005) that approximately a quarter of the Great British Olympic Team have 
asthma/EIB, i.e. more than double the national prevalence of asthma (National Asthma 
Campaign, 2001). 
 
This heightened prevalence is thought to arise due to a combination of the deleterious 
impact of training and competition environmental exposures (e.g. pollution, swimming 
pool chemicals), coupled with the repeatedly high ventilatory requirements, necessitated 
by participation in elite level sport (Argyros et al., 1996). This combination may result in 
airway injury, (Anderson & Kippelen, 2005) leading to a greater propensity to 
bronchoconstriction, during or following vigorous exercise (Anderson & Kippelen, 
2008). In order to investigate the effect of these aforementioned factors on the prevalence 
and pattern of airway dysfunction, sport teams with comparable peak physiological 
demands, but with differing training environments were to be studied. Although limited 
access to high level athletes made the recruitment process challenging, from all the 
available squads, GB Swimming and GB Boxing were the ones that fulfilled the inclusion 
criteria and therefore were selected to participate in the study. Both sports necessitate that 
athletes reach a similar peak heart rate (HR peak) and V̇E (Reis et al., 2012), however both 
the training environment and the duration athletes are exposed to these physiological 
demands differ significantly (Argyros et al., 1996, de Lira et al., 2013, Reis et al., 2012). 
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Elite level swimmers, appear to have an alarmingly high prevalence of EIB (41% - 55%) 
(Dickinson et al., 2005, Castricum et al., 2010). This heightened airway hyper-reactivity 
appears to resolve in retirement from competitive swimming (Helenius et al., 2002). It 
has been proposed that repeated exposure to airborne irritants and sensitizing agents (e.g. 
halocetic acids and trihalomethanes) may drive a sensitisation process and induce airway 
inflammation that increases a propensity to EIB (Anderson & Kippelen, 2008). Despite 
this, a clear relationship between EIB and airway inflammation has not been determined; 
with some studies demonstrating no difference in markers of eosinophilic inflammation 
between pool and non-pool athletes (Martin et al., 2012). In contrast, very little 
information is currently available on exercise associated respiratory problems in elite 
level boxing (de Lira et al., 2013, Smith, 2006).  
 
This study therefore was undertaken with the aim of firstly providing an Ôup-to-dateÕ 
evaluation of the prevalence of EIB in the Great British (GB) elite swimming squad but 
also, for the first time, to establish the prevalence of EIB in a cohort of screened elite-
level boxers. A secondary aim was to compare the EVH challenge response and baseline 
FeNO, as a surrogate of airway inflammation, between two sports with similar peak 




4.3.1 Study design and participants 
 
Adult members (Age > 18 yr) of the elite GB Boxing and GB Swimming squads, 
competing regularly in international competition were recruited, as part of a screening 
study, to assess their airway health. Participants attended the laboratory on a single 
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occasion at various locations between July 2013 and September 2015. Participants were 
invited to take part in the testing regardless of previous diagnosis (Dx) of asthma/EIB.  
 
Athletes were excluded if they had a chest infection within 4 weeks, did not withdraw 
from using their prescribed asthma medications or they had a current FEV1 value of ≤ 
70% predicted. The study was approved by the University Ethics Committee (Reference 
Number: Prop74_2012_13 and Prop82_2013_14) and all participants provided written 
informed consent.  
 
4.3.2 Training environment 
 
The boxing squad trained indoors in gymnasiums with moderate temperatures (19 - 21 
¡C) and relative humidity (40 - 50%) levels (Figure 4.1A). In contrast, the swimming 
squad trained in indoor pools with air temperatures of 29 ¡C with relative humidity above 
60% (Figure 4.1B).  
 
 
Figure 4.1 Training environment 
Panel A shows the GB Boxing training gym and Panel B shows one of the swimming pools 




All pools that swimmers trained in followed WHO Guidelines (World Health 
Organization, 2006) for use of chlorine-based disinfectants. The free chlorine levels were 
maintained at 1 mg/l or below. Combined chlorine (chloramines) levels were never more 
than half the free chlorine, and never more than 1 mg/l. 
 
4.3.3 Study measurements 
 
Participants initially completed a questionnaire, addressing exercise respiratory symptoms 
and environmental triggers. They then completed measurements of FeNO and spirometry, 
followed by an EVH challenge. Participants were requested to avoid high intensity 
exercise and caffeine for four hours prior to the study. Participants with a Dx of 
asthma/EIB were required to withhold inhaled asthma medications according to 
recommendations (Parsons et al., 2007). 
 
4.3.3.1 Fraction of exhaled nitric oxide (FeNO)  
 
A NIOX analyser (NIOX MINO¨, Aerocrine AB, Sweden) was used to measure FeNO in 
the exhaled breath at rest at a flow rate of 50 ml/min (Dweik et al., 2011). FeNO was 
performed prior to spirometry manoeuvres (Kharitonov et al., 1997) and taken as the mean 




Using digital spirometers (Spiro-USBTM and MicroLabTM, CareFusion, Germany), 
participants completed a minimum of three forced maximal flow-volume manoeuvres 
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(Miller et al., 2005). For each maximal flow-volume manoeuvre, the following 
measurements were recorded in accordance to ATS/ERS 2005 Guidelines (Miller et al., 
2005): FEV1, PEF, FVC and FEV1/FVC. 
 
4.3.3.3 EVH Challenge 
 
EVH challenge was conducted in accordance to methods outlined by Anderson et al. 
(2001). Briefly, participants were asked to attain a target V̇E of 85% of their predicted 
MVV rate for 6 minutes and maximal voluntary flow-volume loops were measured at 3, 
5, 7, 10 and 15 minutes (Parsons et al., 2013). The test was deemed positive if the FEV1 
fell by at least 10% from baseline at two consecutive time points (Parsons et al., 2013). 
 
4.3.3.4 Statistical analysis 
 
Normally distributed data were expressed as mean ± SD unless otherwise stated. One-way 
analysis of variance (ANOVA) was performed to compare baseline spirometric indices 
between EVH-positive and EVH-negative participants. Chi-squared (X2) analysis was 
used to evaluate the reported symptoms between EVH-positive and EVH-negative 
participants. To assess the efficacy of self-reported symptoms, sensitivity, specificity and 
diagnostic accuracy were calculated (Zhu et al., 2010). Assumptions of normal 
distribution of FeNO data could not be made therefore SpearmanÕs correlation was used 
to demonstrate the strength and the direction of the relationship between mean FeNO 
values and the maximal fall in FEV1 post-EVH challenge. The results were considered 
significant if p ≤ 0.05. Statistical analysis was performed using statistical package for 




4.4.1 Participant characteristics 
 
Participant characteristics are shown in Table 4.1. Thirty-eight boxers (5 females; 26 
Caucasians) and forty-four swimmers (19 females; 44 Caucasians) completed the study. 
Ten participants (12%) were excluded (N = 6, under age of 18 yr; N = 3 resting airflow 
obstruction; N = 1, equipment failure during testing).  
 
Seventeen (21%) of the participants had a Dx of asthma/EIB. Of these, all were prescribed 
short-acting β2-agonist for use pre-exercise, however in addition four (24%) were 
prescribed inhaled corticosteroid, six (35%) were prescribed an inhaled 
corticosteroid/long-acting β2-agonist combination. One participant (6%) was not using 
any regular asthma medication. 
 
At baseline, when compared against swimmers, boxers had lower baseline FEV1, 
percentage predicted FEV1, FVC, percentage predicted FVC and FEV1/FVC (Table 4.1). 
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Table 4.1 Participant characteristics (mean ± SD) 
!  GB Boxing GB Swimming 
!  Total EVH-positive EVH-negative Total EVH-positive EVH-negative 
N!  38 3 35 44 30 14 
Gender Males 33 (86.8%) 3 (100%) 30 (85.7%) 25 (56.8%) 19 (63.3%) 6 (42.9%) 
Females 5 (13.2%) - 5 (14.3%) 19 (43.2%) 11 (36.7%) 8 (57.1%) 
Age (yr) 22 ± 3 26 ± 2 22 ± 3 21 ± 3 21 ± 3.0 21 ± 2 
Height (cm) 179.8 ± 11.5 183.3 ± 12.1 179.5 ± 11.6 180.4 ± 8.6 180.8 ± 7.4 179.7 ± 11.0 
Weight (kg) 70.9 ± 16.1 74.7 ± 14.4 70.6 ± 16.4 74.5 ± 10.1 73.7 ± 9.4 76.2 ± 11.5 
FeNO (ppb) 40.7 ± 40.9 99.0 ± 86.5 
a
 35.7 ± 32.5 28.1 ± 21.9 32.0 ± 25.0 19.6 ± 8.7 
FEV1 (L) 4.3 ± 0.7 
b
 4.5 ± 1.0 4.3 ± 0.7 4.8 ± 0.9 4.8 ± 1.0 4.9 ± 0.7 
FEV1 (% of predicted) 101 ± 14 
c
 102 ± 10 101 ± 14 113 ± 16 111 ± 15 118 ± 15 
FVC (L) 5.1 ± 0.9 
c
 5.3 ± 1.2 5.1 ± 0.9 6.2 ± 1.1 6.2 ± 1.1 6.2 ± 1.1 
FVC (% of predicted) 102 ± 12 
c
 103 ± 10 102 ± 12 124 ± 12 122 ± 13 128 ± 10 
FEV1/FVC (%) 83 ± 7 
c
 83 ± 3 84 ± 7 77 ± 6 77 ± 6 79 ± 8 
 
a 
Different from EVH-negative boxers (p < 0.05); 
b 
Different from GB Swimmers (p < 0.05); 
c 
Different from GB Swimmers (p < 0.001) 
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4.4.2 Airway response to EVH Challenge and Dx of asthma/EIB 
 
Eighty-two participants completed the EVH challenge, of which thirty-three (40%) had a 
positive EVH challenge. Twenty-two (67%) of these subjects (three boxers and nineteen 
swimmers) had no Dx of asthma/EIB. In contrast, six (12%) participants (all swimmers) 
with Dx of asthma/EIB had a negative EVH result.  
 
Six (12%) EVH-negative athletes (six swimmers) and ten (30%) EVH-positive athletes 
(ten swimmers) reported having previously been diagnosed with asthma/EIB and were 
using one or a combination of short-acting β2-agonists, long-acting inhaled β2-agonists 
and inhaled corticosteroids.   
 
The maximum fall in FEV1 from baseline ranged from - 11.6% to - 21.3% in EVH-positive 
boxers and from - 12.4% to - 56.1% in EVH-positive swimmers. Two boxers and one 
swimmer presented with a FEV1 fall from baseline of > 10% (- 10.1% and - 10.5% for the 
boxers and -10.1% for the swimmer) at only one single time point, deeming them EVH-
negative. Of the thirty-three positive EVH challenges three (7.9%) were elite boxers and 





Figure 4.2 Maximal fall in FEV1 post-EVH challenge showing tests that attained 
60% MVV (vertical line) and tests, that were above and below the 10% fall in 
FEV1 cut-off value (horizontal line) for a positive test. 
Panel A represents GB Boxing and Panel B represents GB Swimming. 
 
 
There was no difference in anthropometric characteristics between EVH-positive and 







Of the EVH-positive participants, fourteen (43%; all swimmers) reported no exercise-
associated respiratory symptoms. However, thirteen (93%) of the fourteen EVH-negative 
swimmers reported at least one exercise respiratory symptom.  
 
There was an inverse relationship between the maximal fall in lung function following 
EVH challenge and self-report of exercise-associated chest tightness (r = - 0.25; p = 0.02) 
and wheezing (r = - 0.25; p = 0.02) in EVH-positive participants. There was also an inverse 
relationship between the maximal fall in FEV1 and reports of increased severity of 
symptoms (r = - 0.35; p = 0.04).  
 
Ten (23%) swimmers reported increased respiratory symptoms due to Òbad pool air and/or 
high chlorine concentrationsÓ and three (7%) swimmers reported exacerbation of 
respiratory symptoms due to Òhot, humid climateÓ. There was no difference in likelihood 
of a positive EVH between these groups; i.e. five were EVH-positive and eight EVH-
negative. Thus overall, the precision of symptoms for a positive EVH test in swimmers 
was poor; specificity values ranging from 19.2% (cough) to 29.4% (breathing difficulty).  
 
4.4.4 Fraction of exhaled nitric oxide  
 
Resting mean FeNO was similar between boxers and swimmers, 40.7 ± 40.9 ppb vs. 28.1 
± 21.9 ppb; p = 0.08, respectively. EVH-positive boxers had greater FeNO values when 
compared to their negative counterparts (99.0 ± 86.5 ppb vs. 35.7 ± 32.5 ppb; p = 0.01). 
There was no difference in FeNO values between EVH-positive and -negative swimmers 
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(32.0 ± 25.0 ppb vs. 19.6 ± 8.7 ppb; p = 0.08). There was a correlation between mean 
FeNO values and the maximal fall in FEV1 post-EVH challenge in swimmers (rs = 0.32; 




It is proposed that the combination of training and performing in noxious environments 
makes certain groups of elite athletes highly susceptible to the development of airway 
dysfunction (Price et al., 2013). The findings from this study supports this notion, 
confirming the very high prevalence of airway hyper-reactivity in elite level swimmers. 
Indeed, to our knowledge, this is the highest prevalence (68%) of airway dysfunction 
reported in an elite internationally-competitive squad of athletes, screened using an 
indirect stimulus for bronchial provocation. In contrast, in a cohort of athletes, who are 
not exposed to the environmental stress of the pool environment (i.e. boxers), the 
prevalence of airway dysfunction was found to be nine fold lower (8%).  
 
The training and competition environment that elite swimmers are exposed to, clearly 
differs from that of elite boxers. In this respect, boxers train indoors in gymnasiums with 
relatively low levels of airborne irritants (e.g. allergens (5 - 10 µm) and ultrafine particles 
(< 0.1 µm)) (Rundell & Sue-Chu, 2013), moderate temperatures and moderate humidity 
levels. In contrast, the elite swimmers we studied trained in high temperature and 
humidity. Previous studies (Helenius et al., 2005, Bernard et al., 2009, Bougault et al., 
2010, Seys et al., 2015)
 
suggest that athletes who regularly attend indoor swimming pools 
are acutely and repeatedly exposed to high concentrations of inhaled surface irritants such 
as chlorine gas derivatives. Repeated exposure to airborne irritants and sensitizing agents 
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can induce an airway inflammation and remodelling process that may lead to the 
development of asthma/EIB (Anderson & Kippelen, 2008, Bougault et al., 2009). It has 
been suggested (Bougault & Boulet, 2013) that the increased occurrence of EIB in 
swimmers may be caused by the combined effects of the inhalation of by-products arising 
from disinfection and high number of training hours. The cohort assessed in this study 
may have had even greater exposure to triggers, as they were part of an elite squad, in 
contrast to other studies (Parsons et al., 2007, Molphy et al., 2014, Mannix et al., 2004) 
that have only tested well-trained and/or sub-elite athletes. Indeed, the prevalence of 
EVH-positive elite swimmers and boxers is notably greater than the only previous report 
of the prevalence of asthma and EIB in GB Olympic Swimmers (41%) (Dickinson et al., 
2005). Although Dickinson et al. (2005) used similar methods to confirm asthma/EIB, 
they did not screen the entire 2004 GB Olympic Team, but only conducted indirect 
bronchoprovocation challenges with athletes who had a Dx of asthma/EIB or at the 
request of a team medical officer.  
 
Recently, Haahtela et al. (2008) recommended distinguishing between two clinical 
phenotypes of asthma in athletes. The first phenotype is characterised by early onset in 
childhood, responsive to methacholine, atopy and signs of eosinophilic airway 
inflammation, and increased FeNO levels. The second one is described with a late onset 
of symptoms during sporting activity, bronchial responsiveness to eucapnic voluntary 
hyperventilation (EVH) but not necessarily to methacholine, with a variable response of 
atopic markers and FeNO (Bussotti et al., 2014). In the entire athletic cohort, no 
significant relationship was found between FeNO values and the maximal fall in FEV1 
post-EVH challenge. This is in keeping with prior publications (Voutilainen et al., 2013, 
Parsons et al., 2012)
 
and indicates that FeNO is a poor predictor of airway hyper-reactivity 
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and clinical asthma in elite athletes. It also supports the hypothesis of Haahtela et al. 
(2008) that when respiratory distress is caused only by extreme exercise and severe 
airway cooling/drying, EIB may really be considered a physiological phenomenon. On 
the other hand, when this association was evaluated in swimmers alone, there was a 
correlation between FeNO and the maximal fall in FEV1 post-EVH challenge, indicating 
that baseline airway inflammation may predict more severe response to EVH.  
 
One of the key findings of this study is the high number of athletes (93%) who reported 
at least one exercise respiratory symptom, despite having been tested negative on the EVH 
challenge. The greatest benefit of the EVH test lies in its high ability to identify athletes 
who truly do not have EIB (Hull et al., 2016). Taking this into account, the high prevalence 
of symptomatic EVH negative athletes in this study suggests that asthma-like symptoms 
and exercise-induced respiratory discomfort are not inevitably caused by underlying 
pathology, but may be related to conditions that mimic EIB, such as DB, which, in the 
lack of diagnostic strategies, may remain unrecognised and untreated. 
 
In total, 22 out of 33 (67%) EVH-positive athletes had no Dx of asthma/EIB. Sixty-three 
percent (19 of 30) of the EVH-positive swimmers had no previous history of EIB, whilst 
none of the EVH-positive boxers had a Dx of asthma/EIB. Moreover, reports of exercise-
associated respiratory symptoms were not predictive for the presence of a positive EVH 
test. It is interesting to note that 26.09% (6 of 23) of the EVH-positive swimmers reported 
of experiencing no respiratory symptoms during or after training.  These findings are in 
agreement with previous studies reporting impaired symptom recognition in athletes 
(Holzer et al., 2002, Bougault et al., 2009, Rundell & Jenkinson, 2002). Athletes may 
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consider their exercise-induced symptoms as a normal effect of high-intensity training, 
therefore they do not report them and their conditions remains unrecognised and untreated. 
 
Additionally, there were six swimmers who had a Dx of EIB, but did not have a positive 
EVH challenge. Of these six athletes, four were using Salbutamol inhaler exclusively, 
one was also prescribed inhaled corticosteroid and one was prescribed an inhaled 
corticosteroid/long-acting β2-agonist combination. Although athletes stopped using 
inhaler therapy prior to the EVH challenge (Parsons et al., 2012), this may not have been 
adequate and athlete may still have received some protection from inhalers. Furthermore, 
a negative indirect airway challenge does not confirm the absence of EIB. An alternate 
test, such as Mannitol or sport specific exercise, may be appropriate to confirm or reject 
diagnosis of EIB. 
 
There is a lack of data to indicate whether initiating treatment in this context has a 
beneficial impact for health and performance (Price et al., 2014b) and indeed the 
relationship between a positive EVH result and Ôin the fieldÕ airway dysfunction is not 
straightforward (Castricum et al., 2010). There has been (Castricum et al., 2010) reported 
a discrepancy between different bronchial provocation tests when they were compared to 
field based exercise challenge tests in the diagnosis of EIB in swimmers. At the current 
time initiation of treatment in asymptomatic EVH-positive athletes with no previous 
history of EIB must be taken on a case-by-case basis. The transient nature of EVH 
positivity can be reduced and/or normalised in swimmers when intense training has ceased 
for a period of at least 15 days (Bougault et al., 2011). These observations suggest that the 





Although participants were encouraged throughout the test, seven athletes (9%) did not 
attain the minimum required percentage of MVV (60%) during the EVH challenge, 
outlined as a criterion for the acceptance of a valid test. This might have happened due to 
three reasons: (1) athletes did not push themselves to attain target V̇E during the test and/or 
(2) did not feel comfortable breathing dry air at high V̇E and/or (3) did not understand the 
test instructions. Despite these, the EVH challenge was able to identify positive 
responders even though they failed to reach the 60% criterion; four of the seven athletes 
had a significant fall in FEV1 post EVH challenge confirming EIB. Those who did not 
provide a positive challenge should be offered another opportunity to complete the EVH 
challenge and achieve > 60% MVV. Alternatively, a different indirect challenge (e.g. 
mannitol challenge) or exercise may be preferred to use in order to rule out EIB in low-
performing individuals, especially if they also present with co-existing indications of EIB 
(e.g. cough or environmental triggers) (Molphy et al., 2014).  
 
Given the elite athletes have very strict schedule and do not all train at the same venue, 
testing days had to take place at various locations and at different times during the year. 
The athletes that demonstrated higher FeNO values in this study were tested during 
summer time. It has been previously reported that FeNO levels are influenced by several 
factors, such as environmental triggers (e.g. seasons), age, height, gender, allergen 
exposure and nitrate intake. The seasonal variation we detected in FeNO levels could be 






The results of this study demonstrate a very high prevalence of airway dysfunction in 
elite swimmers and overall a nine-fold greater prevalence than elite boxers. The findings 
support the notion that athletes who train and compete, for prolonged periods, in 
provocative environments have an increased susceptibility to EIB. Additionally, a high 
proportion of athletes reported symptoms in the lack of objective evidence of airway 
dysfunction, highlighting the demand for a precise investigation of the causative factors 
contributing to the exercise-respiratory symptoms and the need for the development of an 
extended diagnostic algorithm in order to ensure that optimum care is delivered to this 
specific population. Future research should investigate whether a currently available, 
validated symptoms questionnaire have the sensitivity to identify athletes with a positive 
EVH challenge and/or distinguish these athletes from those who may suffer from a 
functional breathing disorder.
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Chapter 5. Prevalence of dysfunctional breathing 
(DB) and its relationship with airway dysfunction 




Introduction: Dysfunctional breathing may mimic and/or co-exist with EIB. The use of 
specific questionnaires could improve the identification of DB in athletes. The NQ has 
been previously used to identify DB across several populations, but not among athletes.  
Aims and objectives: To report the prevalence of DB in a cohort of physically active, 
young adults. In addition, we investigated the factor structure of the NQ in a population 
of recreational athletes. A secondary aim was to evaluate the relationship between NQ 
score and the response to an indirect airway challenge.  
Methods: Healthy, physically active young adults (N = 500) aged 18-35 years provided 
informed consent and completed the NQ. Participants responses to each of the 16 items 
was scored and a positive NQ score indicating DB was set at ≥ 23 out of 64. The 
participants NQ responses were used to investigate the construct validity through 
principal components analysis (PCA). A separate cohort of 104 athletes (mean ± SD age: 
23 ± 4 yr.; N = 79 (76%) males; N = 63 (60.6%) elite athletes underwent an EVH 
challenge and completed the NQ. The cross-sectional and convergent validity of the NQ 
was tested through the PearsonÕs correlation between the NQ total score and baseline 
FEV1 (% of the predicted value), FVC (% of the predicted value), FEV1/FVC (%), MVV 
(%) and FEV1 fall following the EVH challenge. A p value ≤ 0.05 was deemed significant.  
Results: Of the 500 questionnaires distributed, 436 (87%) were returned and 428 (86%, 
N = 283 males) had complete data. Nine percent (9%) of the 428 participants had a NQ 
score ≥ 23, with female predominance. Fifty-two (50%) participants had a positive EVH 
challenge and 17 (16.4%) had a positive NQ score. The sensitivity, specificity, positive 
predicted value (PPV) and negative predicted value (NPV) of a positive NQ score 
predicting EIB were 15.38%, 82.69%, 47.06% and 49.43%, respectively. Principal 
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component analysis revealed a three factor solution with 11 items and 56.20% of 
explained variability. 
Conclusions: The prevalence of athletes with a positive NQ score in athletic population 
is similar to reports in the general population. The NQ score was a poor predictor of 
identifying athletes who would present with a positive EVH challenge. The NQ does not 
appear suitable to detect DB in athletes; therefore, the development of an alternative 






















The results of Chapter 4 highlighted a very important problem surrounding the diagnosis 
of exercise respiratory conditions. From all EVH negative athletes, 93% had a complaint 
of at least one respiratory symptom and 12% had a previous diagnosis of EIB suggesting 
that reports of exercise-associated respiratory symptoms were not predictive for the 
presence of a positive EVH test. This finding supports previous studies (Hanks et al., 
2012, Krieger, 2002) indicating that many athletes who report exercise respiratory 
symptoms have no objective evidence of bronchoconstriction, which is suggestive that 
their symptoms are not related to EIB. 
 
 
Taken together the findings from Chapter 4 and the reports in the existing literature 
continue to confirm and underline the complex relationship between respiratory 
symptoms and the presence or indeed lack of airway dysfunction in athletes (Hull et al., 
2012). Furthermore, it supports the notion that exercise respiratory complaints may occur 
in the absence of organic cardio-respiratory disease (Boulding et al., 2016).  
 
The term dysfunctional breathing describes a maladaptive breathing behaviour that does 
not sit within the traditional clinical diagnosis and cannot be defined through the standard 
assessment methods, therefore remains having an abnormality. It can exist in isolation, 
as a condition without pathology or organic origin, but as an entity, it can also co-exist 
with apparent organic disease causing respiratory and non-respiratory complaints 




Individuals with DB typically describe a myriad of respiratory symptoms including 
variable breathlessness, chest discomfort and an uncomfortable breathing sensation (e.g. 
being unable to Ôobtain a satisfying breathÕ). Specifically, athletic individuals of all 
abilities, frequently report nociceptive and uncomfortable breathing sensations (Boulet et 
al., 2005, Price et al., 2016, Price et al., 2015). These symptoms are similar to those often 
reported by athletes with asthma related conditions (Hull et al., 2012, Price et al., 2015), 
hence it is not uncommon for symptoms of DB to be attributed to the presence of asthma 
or EIB and thus for inappropriate treatment to be prescribed, as seen in Chapter 4. Prior 
to diagnosis of DB, clinicians must first exclude, or adequately treat, organic disease and 
only then can dysfunctional breathing be considered (Morgan, 2002). It is therefore 
recommended that objective tests, such as indirect bronchoprovocation tests (e.g. EVH 
testing) are used in order to obtain a secure diagnosis of a bronchoconstriction related 
condition in athletic individuals (Parsons et al., 2013) and to exclude this organic cause 
as the trigger of exercise respiratory discomfort.  
 
Identifying the cause of the perceived symptoms and distinguishing them from those 
originating from organic respiratory problems require careful evaluation, however, to 
date there exists no clear consensus on a gold standard differential diagnostic tool of this 
kind. Previous methods of diagnosis, however, include ETCO2 measurement, BHT, 
MARM, the SEBQ, and the NQ (Boulding et al., 2016). Although, the latter has been the 
most frequently utilised method (Boulding et al., 2016) in assessing DB in the general 
population (Courtney et al., 2011b), those with anxiety disorders (van Dixhoorn & 
Duivenvoorden, 1985) and patients with co-existing respiratory diseases e.g. asthma 
(Thomas et al., 2001, Thomas et al., 2003, Grammatopoulou et al., 2014), there are no 
reports evaluating NQ outcomes in a cohort of physically active individuals and athletes, 
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among whom the symptoms are very prevalent. 
 
This study was therefore undertaken to investigate the prevalence of NQ positive 
responses in a cohort of physically active, young adults. In addition, the specific symptom 
constellation most commonly reported by those with and without EIB was also evaluated. 
A secondary aim was to directly compare whether an NQ score was related to the outcome 
of an objective testing for EIB and whether a clear separation of DB from a genuine 




The study took place at the School of Sport and Exercise Sciences (SSES), University of 
Kent and was conducted between September 2014 and December 2015. The study was 
approved by the SSES Local Ethics Committee (Ethics Reference Number: Prop 
104_2014_2015). 
 
5.3.1 Study design and participants 
 
Healthy participants (N = 500) aged 18-35 years and physically active were invited to 
participate in a cross-sectional study and complete the NQ. The principal components 
analysis (PCA) that was used to emphasise variation in the dataset, is a large sample 
procedure. Access to the (high) number of elite athletes, that satisfies the requirements of 
this type of statistical test, was not possible within the scope of this study. Therefore, 
participants were recruited from undergraduate and postgraduate sports science and 
sports therapy lectures and practical seminars or from the testing laboratory.  
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A separate cohort of elite (N = 13; cyclists, N = 49; swimmers) and recreational athletes 
(N = 42; from various sports), selected based upon access and availability, also completed 
the NQ, but in addition underwent an EVH challenge to diagnose EIB.  
 
Participants from either of the studied groups were pre-screened for any diseases and 





The questionnaire completed by the participants consisted of two sections. The first 
section asked for demographic information such as gender, age, origin, and physical 
activity. The second section was the NQ.  
 
5.3.2.1 Nijmegen Questionnaire (NQ) 
 
The NQ is a useful tool to quantify and assess the normality of subjective sensations. 
Participants, differently from the standard, validated format of the NQ, were asked to rate 
their symptoms as experienced during bouts of exercise. The NQ consists of 16 items that 
include symptoms common to both anxiety and asthma and relate to different systems, 
such as cardiovascular, neurological, respiratory, gastro-intestinal and psychological 
factors. For each of the 16 items participants rated their experience of the symptom on a 
five-point ordinal scale (where 0 is never and 4 is very often). In keeping with previous 
literature a score of ≥ 23/64 was considered evidence of DB (van Dixhoorn & 
Duivenvoorden, 1985). 
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5.3.3 Spirometry and EVH challenge  
 




, CareFusion, Germany), 
participants completed a minimum of three forced maximal flow-volume manoeuvres.
 
For 
each maximal flow-volume manoeuvre the following measurements were recorded in 
accordance to ATS/ERS 2005 Guidelines (Miller et al., 2005): FEV1, PEF, FVC and 
FEV1/FVC.  
 
An EVH challenge was conducted in accordance to methods outlined by Anderson et al.  
(2001) Briefly, participants were asked to attain a target V̇E of 85% of their predicted 
MVV rate for 6 minutes (calculated by multiplying resting FEV1 x 30).
 
After completing 
the EVH challenge, maximal voluntary flow-volume loops were measured at 3, 5, 7, 10 
and 15 minutes. The test was deemed positive, if the FEV1 fell by at least 10% from 
baseline at two consecutive time points (Parsons et al., 2013). 
 
5.3.4 Statistical Analysis 
 
The statistical package for the social sciences (SPSS Version 22) was used for data 
analysis. Normally distributed data were expressed as mean ± SD unless otherwise stated. 
The validity of the NQ was tested through construct validity using a PCA, in accordance 
with methods outlined by van Dixhoorn et al. (1985) and Grammatopoulou et al. (2014) 
Principal components analysis is a variable-reduction technique that is aimed to reduce a 
larger set of variables into a smaller set of ÔartificialÕ variables (called principal 
components) in order to cluster the most highly related items of the questionnaire (Abdi 
& Williams, 2010) and thus, to exclude those questions that do not measure anything 
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clinically important in the particular study. To identify the number of extracted factors in 
the NQ, the following criteria were used: (1) Eigen values above 1.00, (2) scree plot, (3) 
percentage of explained variability (%) and (4) content of extracted factors. The criteria 
used to retain the respective items were high factor loading (> 0.30) and communality 
above 0.30. The sample adequacy was detected through Kaiser-Meyer-Olkin (KMO) 
measure and Bartlett's test of sphericity. CronbachÕs Alphas were computed for each 
proposed scale to measure internal consistency. One-way ANOVA was performed in 
order to compare baseline spirometric indices between EVH-positive and -negative and 
NQ-positive and -negative athletes. The cross-sectional and convergent validity of the NQ 
was tested through PearsonÕs correlation between the NQ total score and baseline FEV1 
(% of the predicted value), FVC (% of the predicted value), FEV1/FVC (%), MVV (%) 
and FEV1 fall following the EVH challenge. Sensitivity, specificity and diagnostic 




5.4.1 Part I Ð Prevalence of DB and construct validity of the NQ 
 
Of the 500 questionnaires distributed, 436 (87%) were returned and 428 (86%, N = 283 
males) had complete data. The majority of participants were students (N = 389, 91%) and 
Caucasian of origin (N = 278, 65%). The cohort had a mean ± SD age of 21 ± 4 yr.  
 
Participants engaged in 49 different sports, of which the five most popular were football 
(41.1%), basketball (7.0%), strength and conditioning (6.5%), netball (5.4%), and 
running (3.5%). Slightly less than half of the cohort (47.7%) had participated in their main 
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sport for over 10 years. All participants included in the study considered themselves 
physically active; 256 (59.8%) trained one to two days a week, 127 (29.7%) trained three 
to four days a week and 45 (10.5%) trained five to seven days a week. Of the 428 
participants, 110 (25.7%) reported to have a previous diagnosis of an asthma related 
condition at some point in their life, of which, 53 (12.4%) reported a current diagnosis of 
an asthma related condition. 
 
The mean total NQ score was 11.1 ± 7.7 and ranged between 0 and 37. There was a 
difference in mean NQ score between females and males, with females scoring higher 
than males (13.1 ± 7.8 vs. 10.0 ± 7.5; p < 0.001). There was no relationship between NQ 
score and parameters such as age, ethnicity, type or length of sport engagement or weekly 
training time.  
 
A positive NQ score (≥ 23/64) was found in 38 (8.9%) participants. When normalised 
against the total cohort more female (18/145; 12.4%) than male (20/283; 7.1%) 
participants scored above this threshold. There was no difference in mean age between 
NQ positive and negative respondents (20.5 ± 3.6 yr vs. 20.7 ± 3.8 yr; p = 0.74). 
















Table 5.1 Affirmative response rates to NQ components (%)  
 
 
 TOTAL NQ-negative NQ-positive 
 N 428 390 38 
    
NQ1     Chest pain 206 (48%) 168 (43%) 38 (100%) 
NQ2     Feeling tense or agitated 236 (55%) 200 (51%) 36 (95%) 
NQ3     Blurred vision 145 (34%) 113 (29%) 32 (84%) 
NQ4     Dizziness 233 (54%) 197 (51%) 36 (95%) 
NQ5     Confusion 74 (17%) 51 (13%) 23 (61%) 
NQ6     Fast or deep breathing 302 (71%) 264 (68%) 38 (100%) 
NQ7     Shortness of breath 279 (65%) 242 (62%) 37 (97%) 
NQ8     Chest tightness 191 (45%) 154 (40%) 237 (97%) 
NQ9     Bloated abdominal feelings 132 (31%) 108 (28%) 24 (63%) 
NQ10   Tingling fingers 152 (36%) 120 (31%) 32 (84%) 
NQ11   Cannot breathe deeply 128 (30%) 93 (24%) 35 (92%) 
NQ12   Stiffness in fingers or arms 102 (24%) 79 (20%) 23 (61%) 
NQ13   Stiffness around the mouth 47 (11%) 31 (8%) 16 (42%) 
NQ14   Cold hands 193 (45%) 160 (41%) 33 (87%) 
NQ15   Thumping of the heart 226 (53%) 188 (48%) 38 (100%) 
NQ16   Anxiety 221 (52%) 185 (47%) 36 (95%) 
    
 
In NQ-negative respondents, the symptoms with the highest response rates were fast or 
deep breathing (NQ6) (67.7%) and shortness of breath (NQ7) (62.1%). All NQ-positive 
participants reported having experienced chest pain (NQ1), fast or deep breathing (NQ6) 
and thumping of the heart (NQ 15; Table 5.1). 
 
5.4.1.1 NQ structural analysis 
 
In the present study, the recruited sample size (N = 428) was adequate to the pre-
determined factor analytic criteria. To achieve a simple structure to the PCA; items that 
loaded into more than one component following the preliminary analysis, were removed. 
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The removed items were NQ1, NQ10, NQ11 and NQ14. One item (NQ9) in the third 
component had lower correlations than the other items in that set and was therefore also 
removed.  
 
Inspection of the correlation matrix of the remaining 11 items showed that all variables 
had at least one correlation coefficient greater than 0.3. The sample adequacy was detected 
through KMO measure (KMO = 0.80) and Bartlett's test of sphericity (p < 0.001) 
indicating that the data was likely factorisable. A Varimax orthogonal rotation was 
employed to minimise the number of variables that have high loadings on each component 
and, as such, to aid interpretability.  
 
Visual inspection of the scree plot (Figure 5.1) indicated that three components should be 




Figure 5.1 Scree plot of 3-component structure of the overall sample 
The retained components are marked with a full dot. 
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The factor structure of the NQ, eigen values, the percentage of explained variance and 
CronbachÕs alpha values of each component are shown in Table 5.2.  
 




1 2 3 
NQ7     Shortness of breath 0.86 0.11 -0.08 
NQ6     Fast or deep breathing 0.85 0.04 0.02 
NQ8     Chest tightness 0.70 0.20 0.10 
NQ15   Thumping of the heart 0.64 0.23 0.18 
    
NQ3     Blurred vision 0.07 0.77 0.07 
NQ4     Dizziness 0.27 0.72 -0.09 
NQ2     Feeling tense or agitated 0.22 0.65 0.20 
NQ16   Anxiety 0.16 0.60 0.24 
NQ5     Confusion 0.00 0.59 0.24 
    
NQ13   Stiffness around the mouth 0.08 0.12 0.84 
NQ12   Stiffness in fingers or arms 0.04 0.24 0.79 
    
 Eigen values 3.66 1.76 1.09 
 Variance explained (%) 33.28 15.96 9.90 
 CronbachÕs alphas 0.78 0.73 0.60 
    
 
Component 1 Ð Cardiorespiratory symptoms, Component 2 Ð Psycho-neurological symptoms, 
Component 3 Ð Exercise-induced fluid retention symptoms 
 
 
5.4.2 Part II - Relationship between NQ and EIB 
 
A separate cohort of 104 athletes underwent an EVH challenge (Tables 5.3 and 5.4). All 
participants were able to maintain V̇E of > 60% predicted MVV to obtain a satisfactory 
test.
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 TOTAL EVH-positive EVH-negative NQ-positive NQ-negative 
N 104 52 52 17 87 
      
Gender      
      Male 79 (76.0%) 38 (73.1%) 41 (78.8%) 7 (41.2%) 72 (82.8%) 
      Female 25 (24.0%) 14 (26.9%) 11 (21.2%) 10 (58.8%) 15 (17.2%) 
Ethnicity      
      Caucasian 93 (89.4%) 47 (90.4%) 46 (88.5%) 17 (100%) 76 (87.4%) 
      Non-Caucasian 11 (10.6%) 5 (9.6%) 6 (11.5%) - 11 (12.6%) 
Age (yr) 23 ± 4 23 ± 4 24 ± 5 23 ± 4 23 ± 5 
Height (cm) 179.27 ± 8.21 179.85 ± 6.97 178.69 ± 9.33 177.65 ± 8.02 179.59 ± 8.26 
Weight (kg) 73.22 ± 9.77 72.21 ± 8.97 74.23 ± 10.49 71.65 ± 10.33 73.53 ± 9.69 
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Significantly different from EVH-negative athletes (p < 0.05); 
b 
Significantly different from EVH-negative athletes (p < 0.001); 
c
 Significantly different from NQ-negative 
athletes (p < 0.05). 
 TOTAL EVH-positive EVH-negative NQ-positive NQ-negative 
N 104 52 52 17 87 
      
FEV1 (L) 4.64 ± 0.86 4.63 ± 0.91 4.64 ± 0.82 4.63 ± 0.90 4.64 ± 0.86 
FEV1 (% of predicted) 109 ± 14 108 ± 15 109 ± 13 115 ± 14 
c
 107 ± 14 
FVC (L) 5.81 ± 1.10 6.00 ± 1.10 5.62 ± 1.09 5.81 ± 1.08 5.81 ± 1.12 
FVC (% of predicted) 115 ± 14 118 ± 13 
a
 112 ± 15 124 ± 11
 c
 114 ± 14 
FEV1/FVC (%) 80 ± 8 77 ± 7
 b
 83 ± 7 79 ± 6 80 ± 8 
Post-EVH FEV1 (L) 3.97 ± 0.91 3.59 ± 0.85 4.34 ± 0.80 4.09 ± 1.03 3.94 ± 0.88 
Post-EVH FEV1 fall (%) - 15 ± 11 - 22 ± 11 - 7 ± 3 - 13 ± 9 - 15 ± 12 
MVV 125.59 ± 24.39 127.08 ± 23.93 124.10 ± 24.97 126.18 ± 22.43 125.47 ± 24.87 
MVV (%) 90 ± 14 92 ± 15 87 ± 13 92 ± 16 89 ± 14 
      
NQ 13 ± 9 13 ± 9 12 ± 10 28 ± 6 9 ± 6 
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No participant had evidence of airflow obstruction at rest however fifty-two participants 
(50%; N = 43 elite, N = 9 recreational) had a positive EVH test (Figure 5.2).  
 
 
Figure 5.2 Relationship between EVH result and NQ total score 
Maximal fall in FEV1 post-EVH challenge showing tests, that were above and below the 10% 
drop in FEV1 cut-off value (horizontal line) for a positive test and NQ total scores, that were 
above and below the 23 cut-off value (vertical line) for a positive total score. The number of 
participants in each group is presented in brackets. 
 
 
The peak fall in FEV1 from baseline ranged from - 11% to - 57% in EVH-positive and 
from - 0.6% to - 10% in the EVH-negative participants. 
 
The mean total NQ score was 12.5 ± 9.3, a positive NQ score (≥ 23/64) was found in 17 
(16.3%) participants, out of which, 15 (88%) were elite athletes. When normalised against 
the total cohort more female (10/25; 40%) than male (7/79; 8.9%) participants scored 
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above the cut-off threshold. There was a difference in mean NQ score between females 
and males, with females scoring higher than males (20.7 ± 8.6 vs. 9.9 ± 7.9; p < 0.001). 
We found no relationship between NQ score and parameters such as age or ethnicity.  
 
Elite athletes scored higher on the NQ when compared to the recreational group (14.3 ± 
10.4 vs. 9.8 ± 6.8; p = 0.01). The range of scores obtained by elite athletes (0 - 40) was 
also greater in comparison to the recreational respondents (0 - 27). 
 
Baseline spirometric indices were greater in the NQ positive group; specifically, FEV1 
(107 ± 14 % predicted vs. 115 ± 14 % predicted; p = 0.05) and FVC values (113.51 ± 
14.27 L vs. 123.59 ± 10.78 L; p = 0.01). 
 
There was no difference in ventilation achieved during the EVH test between NQ positive 
and negative athletes (126.18 ± 22.43 L/min vs. 125.47 ± 24.87 L/min; p = 0.54). The 
maximum fall in FEV1 from baseline ranged from - 1.9% to - 37.5% in NQ-positive and 
from - 0.6% to - 57.2% in NQ-negative participants.  
 
There was a weak relationship between average NQ score and the maximal fall in FEV1 
post-EVH challenge in the recreational group (r = 0.32; p = 0.04), however, in the elite 
athletes there was no statistically significant correlation (r = - 0.80; p = 0.54).  
 
Sensitivity, specificity, PPV, NPV, and predictive values for the total screened population 






Table 5.5 Discriminant validity.  
 
 
A. TOTAL Elite athletes Recreationals 
Prevalence (%) 16.35 24.19 4.76 
Sensitivity (%) 47.06 53.33 0.00 
Specificity (%) 49.43 25.53 77.50 
PPV (%) 15.38 18.60 0.00 
NPV (%) 82.69 63.16 93.94 
Accuracy (%) 49.04 32.26 73.81 
Likelihood ratio (LR+) 0.93 0.72 0.00 
Likelihood ratio (LR-) 1.07 1.83 1.29 
 B. TOTAL Elite athletes Recreationals 
Prevalence (%) 50.00 69.35 21.43 
Sensitivity (%) 15.38 18.60 0.00 
Specificity (%) 82.69 63.16 93.94 
PPV (%) 47.06 53.33 0.00 
NPV (%) 49.43 25.53 77.50 
Accuracy (%) 49.04 32.26 73.81 
Likelihood ratio (LR+) 0.89 0.50 0.00 
Likelihood ratio (LR-) 1.02 1.29 1.06 
 
Panel A shows the efficacy of the EVH challenge in predicting a positive NQ score. Panel B shows 
the efficacy of the NQ in predicting EIB. 
 
 
In the assessment of the efficacy of the NQ in predicting a positive EVH challenge, 





This study reveals that approximately one in ten physically active, young adults report 
troublesome symptoms suggestive of DB. Despite asking our participants to respond the 
NQ specifically to exercise, the number of those that had a NQ positive score (≥ 23) was 
similar to that reported by Thomas and colleagues (Thomas et al., 2005). The estimated 
prevalence of NQ positive individuals in their adult population was 9.5%.  
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In our cohort of recreational athletes, females tended to be more likely to score higher on 
the NQ, which is similar to previous reports of female participants providing higher NQ 
scores when compared to males (12.4% vs. 7.1%, respectively) (Thomas et al., 2001, 
Grammatopoulou et al., 2014, Thomas et al., 2005). It has been demonstrated (Lamprecht 
et al., 2013) that females report more dyspnoea and cough when compared to males with 
the same degree of lung function impairment. One possible explanation may be a varying 
anatomy in the size of the lungs, airways and respiratory musculature between the two 
genders. These differences account for a relatively reduced maximum ventilatory reserve 
capacity, lower inspiratory and expiratory pressures and smaller laryngeal dimensions in 
females (R¿ksund et al., 2015, Lamprecht et al., 2013, Weiss & Rundell, 2009). In 
addition, neurobiological studies have demonstrated females have a higher intrinsic 
sensitivity to noxious somatic sensations, including dyspnoea (Lamprecht et al., 2013). 
 
Athletes are more susceptible to EIB than the general population (Bonini & Palange, 
2015) and as outlined above, the co-existence of DB may confound diagnostic accuracy. 
We therefore undertook a sub-study to evaluate the relationship between a common DB 
questionnaire and solid objective evidence of EIB, from an EVH challenge. In this study, 
thirty-five (74.5%) of the NQ negative athletes tested positive on the EVH. These findings 
are in line with previous reports (Rundell et al., 2001) that demonstrated that only half of 
athletes who had EIB reported any respiratory symptoms and that only 28.6% of 
symptomatic athletes could provide objective evidence of asthma (Lund et al., 2009). 
Furthermore, the NQ appears to have a low level of sensitivity (15.38%) but a greater 
degree of specificity (82.69%) in predicting a positive EVH challenge. 
 
 90 
Eight (47.1%) NQ positive individuals (all elite athletes) had a positive result on the EVH 
challenge. In contrast, none of the NQ positive recreational athletes had a positive EVH 
challenge suggesting that to a certain extent, NQ may have a greater potential in 
differentiating EIB from DB in recreational athletes than in high level sports.  
 
Killian et al. (1984) previously demonstrated a positive relationship between lung 
volumes and the perceived magnitude of respiratory effort and breathlessness within 
individuals. They found there was an increase in these parameters when the tension 
developed by the inspiratory muscle increased and when the muscle was weakened due 
to shortening of its operating length (Killian et al., 1984). A positive correlation, similar 
to those detected by Killian et al. (1984), was observed in this present study, however the 
finding was novel in that, this positive correlation was found between, rather than within 
individuals. Within-person variation shows whether and how quickly one is adapting to 
a transition or stressor, but in contrast, between-person variation reflects on individual 
differences. In this study, athletes with a positive NQ score had significantly higher lung 
function values when compared to their NQ negative counterparts, however, the clinical 
implication of this, if there exists any, is yet to be determined. 
 
The PPV (47.06%) and NPV (49.43%) of self-reported symptoms on the NQ 
demonstrated only modest value in predicting clinical diagnosis, which might be due to 
impaired symptom recognition in elite athletes, especially in swimmers, who reportedly 
consider their exercise-induced symptoms as a normal effect of high-intensity training, 
therefore they do not report them (Turcotte et al., 2003). Additionally, symptoms (e.g. 
cough) may manifest in relation to cold air inhalation or only in provocative environments 
(e.g. chlorine exposure in swimming pools). Given the fact that the NQ in its current form 
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is Ònon-specificÓ, the aforementioned factors may have impacted the outcome of this 
study. 
 
The construct validity of the NQ was originally reported for a relatively small sample of 
adults (N = 75) from the general population with and without HVS, with 16 items 
classified under three factors (shortness of breath, peripheral and central tetany) (van 
Dixhoorn & Duivenvoorden, 1985). In contrast, our sample size was adequately large for 
the PCA, as defined by Comrey and Lee (1992) and differently from previously studied 
populations, consisted of physically active, young adults. Therefore, by determining the 
dimensional structure of items included in the questionnaire, we aimed to establish 
whether the same factorial structure was evident for our sample of participants.  
 
In comparison to previous reports, that aimed to investigate the efficacy of NQ in 
recognising HVS (van Dixhoorn & Duivenvoorden, 1985) and hyperventilation among 
asthmatics (Grammatopoulou et al., 2014), in the physically active young adult 
population assessed in this study, results showed a different pattern both in terms of 
dimensional structure and items loading. Principal component analysis in our cohort 
revealed three components, that differ from those described by van Dixhoorn et al. (1985). 
In this study, the first component comprised of four items, namely shortness of breath 
(NQ7), fast or deep breathing (NQ6), chest tightness (NQ8) and thumping of the heart 
(NQ15), which having been tightly linked to either the respiratory or cardiovascular 
system, we labelled as ÔCardiorespiratory symptomsÕ. Anxiety (NQ16) with the 
perception of feeling tense (NQ2) comprises the major asthma co-morbidity, increasing 
the risk of hyperventilation in the disease. Dizziness (NQ4) and confusion (NQ5) are 
symptoms related to disturbances in the nervous system and may be linked to anxiety and 
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hypocapnia. Blurred vision (NQ3) was previously reported by patients with asthma-like 
symptoms without physiological sign of asthma (Grammatopoulou et al., 2014). The 
second component was formed by these five items and due to the nature of these 
symptoms, they got labelled as ÔPsycho-neurological symptomsÕ. Prolonged sweating, 
excessive fluid consumption during exercise may result in an increase of total body fluid 
and a decrease in plasma sodium concentration leading to neurophysiological changes 
that may be responsible for the two items that loaded into the third component, namely 
stiffness around the mouth (NQ13) and stiffness in fingers (NQ12), which we labelled as 
ÔExercise-induced fluid retention symptomsÕ. The third component only contained two 
items and had low reliability compared to the first two components, indicating that it may 
not reliably measure DB dimensions; this component could be improved in the future by 
adding more items to it to increase its internal consistency estimate.  
 
In many cases the trigger of breathing discomfort, which can be related to a specific 
episode of stress such as excessive aerobic training (Courtney, 2009), initiates a transition 
from an intermittent, appropriate adoption of an altered breathing pattern to an 
inappropriate maintenance of disordered breathing. Altered motor recruitment pattern of 
the respiratory muscles can lead to increased workloads, reduced mechanical advantage 
and increased ventilatory requirements (Chaitow et al., 2014a). Consequently, an 
inefficient breathing pattern may lead to breathlessness that may be indicative of 
suboptimal function elsewhere than in the lungs and/or the larynx and may not even 
represent pathological condition (Johansson et al., 2015).  
 
Dysfunctional breathing is thought to be a key cause of exertional dyspnoea, however, 
due to the lack of established gold standard diagnostic method for the differentiation of 
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DB from other, often co-existent respiratory diseases, difficulty arises when trying to 
untangle which conditions are contributing to a given individualÕs exertional symptoms.  
Many of the studies assessing the epidemiology of DB use the NQ as a method of 
diagnosis, however, we have shown that several NQ questions are not relevant for athletic 
populations. We used PCA to reduce the original set of variables into a smaller set of 
uncorrelated components in order to provide an adequate representation of the 
information in this specific cohort of participants, with a smaller number of variables 
constructed as linear combinations of the originals. Our analysis suggests, a shortened 
11-item model of the NQ represents the information found in the original set of variables 
and shows a novel pattern in symptoms that are most likely related to exercise.  
 
Although factor analysis suggested the possibility of reducing the NQ to 11 items, it 
would be premature to simply produce a shortened 11 item NQ for athletic populations. 
Additional items, such as psychosocial attributes and sport specific respiratory symptoms, 
should be added to make the NQ specific to exercise and reflective of all possible aspects 
of DB (e.g. origin, onset and manifestation of the condition). Based on the above, the 
obvious next step in this thesis would have been developing a new questionnaire, however 
in the absence of established diagnostic method for DB, it would not have been feasible 
to validate the questionnaire and evaluate whether it measures what it is supposed to 
measure and performs as it is designed to perform. Hence, a gold standard diagnostic tool 
for DB should be identified prior to undertaking further work towards the elaboration of 







Self-reported questionnaires have a number of commonly recognised limitations that 
reduce their usefulness in a research or clinical setting. In particular, reports of symptom 
measures reflect subjective experience and symptom perception rather than objective 
health status; symptom reports do not necessarily reflect illness (van Wijk, Cecile MT 
Gijsbers et al., 1999). Under-reporting may also be a concern, as it relies on the recall of 
respondents, who although employ a wide range of cognitive processes in formulating 
their responses, may not pay attention as they answer the questions (Krosnick, 2000) or 
have trouble understanding the terms used in the questionnaire (Fricker et al., 2000). 
 
Although the 16 items of the questionnaire remained unchanged, participants were asked 
to rate their symptoms as experienced during bouts of exercise, differently from the 
original questionnaire, in which specific circumstances related to symptom occurrence 
were not defined. Although this slight modification of the NQ presumably added clarity 
for respondents without sacrificing the questionnaireÕs psychometric properties, a 




In this study, a DB prevalence of 9% was observed in an athletic population. Female 
athletes tended to be more likely to report symptoms of DB. The NQ score was a poor 
predictor of identifying athletes who would present with a positive EVH challenge.  
Although the development of a new questionnaire may enable a better recognition of DB 
and consequently lower the cost associated with inappropriate diagnosis and therapy, to 
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date, there exists no gold standard clinical assessment for DB to validate a new 
questionnaire against, without which, its application would not be clinically justified. 
Therefore, instead of focusing exclusively on symptoms, investigations should be 
undertaken in order to discern whether the presence of respiratory complaints of non-
organic origin is accompanied by any physiological and/or biomechanical alterations and 





















Chapter 6. The impact of upper thoracic posture 





Introduction: The posture an athlete holds during exercise may alter breathing pattern 
and increase reports of exercise induced respiratory symptoms.  
Aims and objectives: The purpose of this study was to investigate the effect of different 
postural positions during high-intensity cycling on breathing frequency (BF), tidal 
volume (VT), ratings of perceived exertion (RPE) and dyspnoea. 
Methods: Fifteen healthy male athletes (mean ± SD age: 26 ± 7 yr) performed a 10-
minute cycling test at 70% of their peak power in two conditions, in a randomised order: 
with normal shoulder position (C1) and with hunched shoulders (C2). BF and VT were 
continuously monitored during exercise. RPE and dyspnoea were gauged by using Borg 
RPE and Borg-CR10 scales, respectively. 
Results: BF and VT showed no significant difference between conditions at any time 
point, however an alteration in BF was observed in C2.  Significant main effects of time 
emerged for BF, RPE and dyspnoea in both conditions (all p values < 0.001).  
Conclusions: Cycling with hunched shoulders at high intensities over a prolonged period 
leads to altered breathing mechanics and as a consequence, an increase in perceived 
exertion and dyspnoea. These findings suggest that posture may contribute to reports of 










Interest has increased in incorporating questionnaires into clinical practise, as they are a 
quick and more importantly cost-effective way of assessing medical conditions. They 
have strong evaluative and discriminative properties and if designed well, they minimise 
bias and maximise precision in the estimates of treatment effect within budget. Although 
using a questionnaire, as an assessment tool, would be beneficial in establishing an early 
diagnosis of DB, Chapter 5 highlighted that NQ in its current format is inadequate in 
identifying DB and/or differentiating it from other exercise-respiratory conditions and the 
development of a new questionnaire is not feasible due to current gaps in diagnostic 
measures. These findings suggest to shift the research focus from symptom recognition 
to the aetiology of DB by primarily exploring the physiological and biomechanical 
properties of the condition. 
 
Exertional dyspnoea is reported to be the most common symptom, limiting performance 
and/or enjoyment of sporting activities among athletic individuals of all abilities and ages 
(Welsh et al., 2004). Indeed, some describe the sensation of exercise dyspnoea as the 
main barrier to participation in physical activity and/or high performance sport (Williams 
et al., 2008). It is often an interrelated symptom in athletes (Smoliga et al., 2016) and may 
manifest as hyperventilation, or symptoms that occur in association with hypocapnia and 
respiratory alkalosis (Boulding et al., 2016). It is likely to arise as the result of a complex 
interplay of factors including altered subjective awareness (Hayen et al., 2017). 
 
Dysfunctional breathing (DB) is now thought to be a key cause of exertional dyspnoea 
and can be defined as an inappropriate breathing pattern, which is persistent enough to 
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cause symptoms without evidence, or despite optimisation of, any underlying organic 
cause, e.g. EIB (Bradley & Esformes, 2014). Currently there is no gold standard 
diagnostic method for the differentiation of DB from other, often coexistent respiratory 
diseases, and therefore difficulty arises when trying to untangle which conditions are 
contributing to a given individualÕs exertional symptoms.  
 
Hodges & Gandevia (2000) previously reported that a deviation away from an optimal 
breathing pattern can affect the pressure, ventilatory volumes, stability and ultimately the 
work of breathing. They suggested that once the maladaptive pattern is established, the 
impaired breathing movement becomes habituated and thus a self-perpetuating entity 
(Hornsveld et al., 1996).  
 
Anecdotally, athletes with DB often appear to ride in hunched aerodynamic position to 
minimise their frontal area in order to maximise speed. It has been shown that breathing 
efficiency is likely to be compromised in this position and has a negative impact on 
respiration and performance (Chaitow et al., 2014f). 
 
In a recent study, Hayen et al. (2017) used functional neuroimaging to identify the neural 
correlates of the conditioned response to breathlessness and their modulation by the mu-
opioid receptor agonist short-acting synthetic opioid analgesic drug. Their findings 
suggest that opioids palliate breathlessness through an interplay of altered associative 
learning mechanisms, independent of or in addition to effects on brainstem respiratory 




As described above, altered breathing patterns have immediate negative effects on 
postural stability. In many cases the trigger, which can be related to a specific episode of 
physical stress such as excessive aerobic training (Courtney, 2009), initiates a transition 
from a sporadic, altered breathing pattern to a sustained disordered breathing. Although 
exercising in sitting or supine positions, due to mechanical differences, have been 
reported to result in significant differences in V̇E and VT (Takahashi et al., 1998), little is 
known as to whether a change in body position alters respiratory parameters or indeed 
perception of breathing.  Thus Chapter 6 aimed to establish whether this phenomenon 
profoundly influence the physiology and perception of respiration during high intensity 




6.3.1 Study design and participants 
 
Based on observational experience, athletes with DB, regardless of the type of sport they 
are engaged in, are characterised by hunched shoulders with an anteriorly tipped shoulder 
blade and forward head, typically exhibiting wheeze and tightness of their upper chest 
when reaching high intensities during exercise. Due to the difficulties of recruiting a 
sufficient number of individuals of this kind, healthy participants were invited to take part 
in the study with the aim of reproducing an experimental set up, which is similar to that 
seen in real-life DB.  
 
According to the original study plans, on an additional visit reflective makers would have 
been placed on the bare chest of the studied participants in order to investigate chest and 
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abdominal motion using OEP. It would have been technically more challenging to perform 
the assessment on females (due to markers placement and difficulty in recruitment), 
therefore only male participants were included in the study.   
 
Recreational athletes, who exercised at least twice weekly, were invited to take part. To 
ensure that participants were at good respiratory health, inclusion criteria included a score 
less than 23 on the NQ and a negative response to the EVH test. Participants were excluded 
from study measurements, if they had a chest infection within 4 weeks, any other illnesses 
within 2 weeks prior to the tests, had any respiratory or cardiovascular problems, 
metabolic diseases, neurological conditions, they were injured or had any conditions that 
limited mobility.  
 
On test days, participants were instructed to attend the laboratory in a rested state, having 
abstained from high-intensity exercise within the previous 24 hours, and abstained from 
food, alcohol, sports drinks or caffeine intake for the preceding 3 hours. Visits were 
separated by at least 48 hours but no longer than 1 week.  
 
The study was approved by the University of Kent Ethics Committee (Ethics Number: 
Prop17_2013_14) and all participants provided written informed consent.  
 
6.3.2 Experimental design 
 
Participants attended the laboratory on four separate occasions within a 2-week period. 
On the first visit, participants completed the NQ and underwent spirometry measurements 
followed by an EVH challenge test (Anderson et al., 2001). On the second visit, 
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participants performed an exercise test to volitional exhaustion on a cycle ergometer to 
determine peak aerobic power (PAP) and V̇O2 peak. The final two visits required 
participants to complete two 10-minutes cycling tests at 70% of their PAP in two randomly 
ordered cycling positions; either with normal shoulder position (C1) or with hunched 
shoulders (C2). Hunched shoulder positioning was chosen as an experimental condition 
in order to replicate the body posture observed in athletes with DB. An overview of the 




Figure 6.1 Overview of the experimental design 
 
 
6.3.3 Study measurements 
 
6.3.3.1 Nijmegen Questionnaire (NQ) 
 
Participants completed the modified NQ questionnaire described in Chapter 5.  
 
6.3.3.2 Spirometry and EVH challenge 
 
Forced maximal flow-volume manoeuvres and the EVH challenge were conducted in 






Peak aerobic power 
test (V̇O2peak test) 
Visit 3 & 4
10-minutes cycling 
tests at 70% of PAP
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6.3.3.3 Peak Aerobic Power (PAP) test  
 
Participants performed a standardised incremental exercise test on a cycle ergometer 
(Lode - Corival, Groningen, The Netherlands) to volitional exhaustion in order to 
determine PAP. Expired air was analysed breath-by-breath using Cortex Metalyser 3b 
(CORTEX Biophysik GmbH, Leipzig, Germany). The exercise protocol was preceded 
with a 2-minute rest period followed by unloaded pedaling for 3 minutes. Power output 
was then increased by 25 W every minute; participants were instructed to maintain their 
preferred cadence throughout the test (range 60 - 90 RPM). The test was terminated upon 
volitional exhaustion or when the required cadence could no longer be maintained (i.e. 
dropped by > 10 RPM). Throughout the test participantsÕ HR was monitored using a Polar 
RS400 watch (Polar Electro Oy, Kempele, Finland). Capillary fingertip blood samples (5 
- 10 µl) were taken at rest and within 1 minute of exercise cessation. Perceived exertion 
and perceived dyspnoea were assessed at the end of each testing stage by using Borg 
ratings of perceived exertion (RPE) (ratings between 6 - 20) and Borg-CR10 scales 
(ratings between 0 - 10), respectively (Borg, 1998). The RPE scale is used to subjectively 
determine exercise intensity levels. In contrast, the Borg-CR10 scale is a general method 
for measuring most kinds of perceptions and experiences, including pain and other 
sensations (e.g. discomfort) (Borg, 1998). The scale is commonly used for measuring 
dyspnoea and other kinds of somatic symptoms.  
 
All participants fulfilled ≥ 2 secondary criteria for a valid assessment of the maximal 
aerobic capacity, as reaching a RER ≥ 1.10, end-exercise blood lactate concentration ≥ 8 
mmol/L and a RPE ≥ 17 (American College of Sports Medicine, 2013). 
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6.3.3.4 Exercise test at 70% of PAP 
 
Participants performed an aerobic exercise test on a cycle ergometer (Lode - Corival, 
Groningen, The Netherlands). Protocol started with a 2-minute rest period followed by 
unloaded pedaling for 3 minutes. Participants were then asked to maintain a power output 
of 70% of the PAP for 10 minutes. During this period, participants were asked to maintain 
a self-selected cadence between 60 - 90 RPM. The protocol ended with a recovery period 
of 5 minutes with no resistance.  
 
Participants completed the 10-minutes cycling challenge under two conditions: in natural 
shoulder position (C1) and with hunched shoulders (C2). Participants completed the 
exercise trials under C1 and C2 conditions in random order, assigned using simple 
randomisation procedures (computerised random numbers). The trials were performed at 
the same time of the day (within 2 hours) to minimise diurnal variation in exercise 
capacity. An overview of the experimental protocol of Visit 3 and 4 is provided in Figure 
6.2.  
 
Figure 6.2 Overview of the experimental protocol (Visit 3 & 4) 
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Electromyographic (EMG) signals (Acknowledge, Version 4.1 for MP Systems, Biopac 
Systems Inc., Goleta, USA) were used to monitor muscular activity of shoulder region 




Figure 6.3 Experimental set up during the 10-minutes cycling test 
Panel A shows the participant sitting on the exercise bike and Panel B shows the 
computer screen with the EMG signals recorded during muscular contraction and 
relaxation 
 
The electrodes were placed over the upper left and right trapezius midway between the 
acromion and vertebra prominents. Reference electrodes were placed on the mastoid 
behind the ears. Participants were instructed to monitor their shoulder movement on the 
computer screen connected to the EMG unit and placed in front of the cycle ergometer. 
When shoulders were relaxed and there was no muscle contraction, a flat line occurred 
and when shoulders were contracted, motor-unit action potentials (MUAPs) were 
displayed on the screen aiding the participants to perform the tasks (C1 and C2 conditions) 
as instructed.  
A. B. 
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ParticipantsÕ HR was monitored using a Polar RS400 watch (Polar Electro Oy, Kempele, 
Finland). Capillary fingertip blood sample (5 - 10 µl) was taken at rest and within 1 minute 
after finishing exercise. Tidal volume, BF, V̇E, TiTo, V̇O2, V̇CO2, HR and RER were 
recorded by the BbB analyser. Perceived exertion, perceived dyspnoea and leg pain were 
assessed during exercise by using Borg RPE, Borg-CR10 and Pain scales (ratings between 
0 - 10), respectively (Borg, 1998). 
 
6.3.4 Statistical Analysis 
 
Assumptions of statistical tests such as normal distribution and sphericity of data were 
checked. The dependent variables analysed were: VT, BF, V̇E, TiTo, V̇O2, V̇CO2, HR, 
RER, perceived exertion, perceived dyspnoea and leg pain. Paired t-tests were used to 
assess differences of the variables between conditions if normally distributed. Two-way 
repeated measures ANOVA were conducted to test the effect of the two conditions (C1, 
C2) and time (E3, E5, E7 and E10 of the 10-minute cycling test, where E3 represents the 
third, E5 the fifth, E7 the seventh and E10 the tenth minutes of the cycling test) on the 
dependent variables. Studentised residuals were used to assess normality and the presence 
of outliers (± 3 SD). Greenhouse-Geisser correction to degrees of freedom (ε < 0.75) was 
applied when violations of sphericity were present. Significant main effects of time with 
more than two levels and significant interactions and main effects were followed up with 
simple main effects of time or condition (pairwise comparisons) using Bonferroni 
adjustment. Significance was assumed if p ≤ 0.05 (two-tailed) for all analyses. Statistical 
analysis was performed using Statistical Package for Social Sciences, Version 22 for Mac 





6.4.1 Participants characteristics  
 
Fifteen participants completed the study. ParticipantsÕ demographics and respiratory 
parameters are shown in Table 6.1.  
 
Table 6.1 - Participants demographics and physiological characteristics at rest (Visit 
1)  
 





26 ± 7 
178.5 ± 5.9 
Weight (kg) 74.5  ± 12.7 
NQ score 6  ± 5 
  
FEV1 (L) 4.59  ± 0.71 
FEV1 (predicted %) 106  ± 12 
FVC (L) 5.45  ± 0.90 
FVC (predicted %) 106  ± 14 
FEV1/FVC (%) 84  ± 6 




6.4.2 Participants characteristics at peak exercise 
 
ParticipantsÕ physiological and perceptual parameters assessed during the aerobic 




Table 6.2 - Participants physiological characteristics and perceptual parameters at 
the peak exercise (Visit 2) 
 
Parameter (at maximal exercise) N = 15 mean ± SD 
  
V̇O2 peak /kg (ml/kg/min) 49.6 ± 8.4 
V̇O2 peak (L/min) 89.6 ± 14.3 
V̇CO2 (L/min) 125.6 ± 24.4 
HR max (bpm) 181 ± 11 
VE (L/min) 133.3 ± 21.8 
VT (L) 3.0 ± 0.7 
RER 
BF (/min) 
1.23 ± 0.40 
46.7 ± 9.2 
WR (W) 283 ± 47 
RpM (/min) 71 ± 8 
La (mmol/L) 11.01 ± 2.04 
RPE 18 ± 2 




6.4.3 Cycling trials at 70% of maximal aerobic power 
 
6.4.3.1 Effects of posture on respiratory parameters (VT, BF, V̇E and TiTo) 
The C2 had no effect on any of the respiratory parameters (Table 6.3 and Figure 6.4). 
There was a significant time effect for BF, V̇E and TiTo (all p values < 0.05), meaning 
that hunched position had a significant effect on the listed dependent variables over time. 
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Table 6.3 Physiological and perceptual parameters (mean ± SD) during the 10-minute cycling test (at minutes 3, 5, 7 & 10) in C1 and C2 
 



















          
VT (L) 2.6 ± 0.6 2.7 ± 0.7 2.7 ± 0.7 2.7 ± 0.8  2.7 ± 0.7 2.7 ± 0.7 2.7 ± 0.8 2.6 ± 0.8 
BF (/min) 29.4 ± 6.4 33.2 ± 6.9 35.7 ± 8.0 39.6 ± 10.9  29.6 ± 6.2 33.5 ± 7.6 36.9 ± 8.9 42.1 ± 11.4 
V̇E (L/min) 74.3 ± 13.9 85.2 ± 13.2 92.2 ± 15.9 99.7 ± 20.3  75.1 ± 13.6 85.5 ± 12.9 93.9 ± 15.0 103.5 ± 15.9 
TiTo (%) 47.7 ± 2.0 47.9 ± 2.6 48.3 ± 2.8 49.0 ± 2.6  47.1 ± 3.8 47.1 ± 3.6 47.8 ± 3.3 48.7 ± 3.2 
HR (bpm) 147 ± 11 157 ± 12 164 ± 13 171 ± 14  149 ± 10 160 ± 11 167 ± 12 172 ± 12 
V̇O2 (L/min) 2.7 ± 0.4 2.9 ± 0.4 3.0 ± 0.4 3.1 ± 0.4  2.7 ± 0.4 2.9 ± 0.4 3.0 ± 0.4 3.1 ± 0.4 
V̇CO2 (L/min) 2.9 ± 0.5 3.2 ± 0.4 3.2 ± 0.4 3.3 ± 0.4  2.9 ± 0.5 3.1 ± 0.5 3.3 ± 0.5 3.3 ± 0.5 
RER 1.11 ± 0.07 1.10 ± 0.05 1.08 ± 0.05 1.06 ± 0.04  1.11 ± 0.07 1.10 ± 0.06 1.08 ± 0.05 1.07 ± 0.04 
Borg-CR10 score 3.1 ± 1.6 4.2 ± 1.7 5.1 ± 1.9 6.4 ± 2.4 
a
  3.3 ± 2.0 4.7 ± 2.0 5.8 ± 2.1 7.4 ± 2.2 
RPE score 12 ± 3 13 ± 2 15 ± 2 15 ± 3  12 ± 2 13 ± 2 15 ± 2 16 ± 2 
Pain score 3 ± 2 4 ± 2 5 ± 2 6 ± 2  3 ± 2 4 ± 2 5 ± 3 6 ± 3 
 
a




Figure 6.4 The effect of body position on respiratory parameters. 
Panels: tidal volume (A), breathing frequency (B), minute ventilation (C) and ratio between 
inspiratory time and total breath time (D). Data are presented as mean ± SEM. ** Significant 
main effect of time (p < 0.001). C1 represents ÔCondition 1Õ (normal shoulder position) and C2 
represents ÔCondition 2Õ (hunched shoulder position). E3, E5, E7, E10 represent minutes 3, 5, 7 
and 10 of the 10-minute cycling test. 
 
 
6.4.3.2 Effects of posture on heart rate and gas exchange parameters (HR, RER, V̇CO2, 
V̇O2) 
 
Heart rate increased in a similar pattern over time in both conditions (Figure 6.5). HR, 
V̇CO2 and V̇O2 did not show any significant interaction or main effect of condition, 
however they changed significantly over time (all p values < 0.001) (Figure 6.5). There 
was a statistically significant mean difference in RER between the following time points: 
E3 and E10 (0.44 ± 0.12; p = 0.01), E5 and E7 (0.20 ± 0.06; p = 0.03) and E5 and E10 




Figure 6.5 The effect of position on cardio and respiratory gas parameters 
Panels: heart rate (A), respiratory exchange ratio (B), oxygen uptake (C) and carbon dioxide 
output (D). Data are presented as mean ± SEM. ** Significant main effect of time (p < 0.001). 
## Significant main effect of time (p < 0.001), except in C1 (E3, E5), (E3, E7) and (E7, E10). 
C1 represents ÔCondition 1Õ (normal shoulder position) and C2 represents ÔCondition 2Õ 
(hunched shoulder position). E3, E5, E7, E10 represent minutes 3, 5, 7 and 10 of the 10-minute 
cycling test. 
 
6.4.3.3 Effects of posture on perceptual parameters (perceived exertion, perceived 
dyspnoea, leg pain) 
 
Ratings of perceived dyspnoea (as indexed by the Borg-CR10 scale) significantly differed 
in the two conditions in the final minute of the cycling test (6.4 ± 2.5 vs. 7.4 ± 2.3, in C1 
and C2, respectively; p ≤ 0.05) (Table 6.3), but RPE and Pain scores were not affected by 




Figure 6.6 The effect of body position on perceptual parameters 
Panels: perceived dyspnoea (A), perceived exertion (B) and leg pain (C). Data are presented as 
mean ± SEM. * Significant difference between C1 and C2 (p ≤ 0.05). ** Significant main effect 
of time (p < 0.001). ## Significant main effect of time (p < 0.001), except (E3, E5) and (E7, 
E10) in C1. C1 represents ÔCondition 1Õ (normal shoulder position) and C2 represents 
ÔCondition 2Õ (hunched shoulder position). E3, E5, E7, E10 represent minutes 3, 5, 7 and 10 of 
the 10-minute cycling test. 
 
 
There was a significant condition-time interaction between time across conditions and 
both perceived exertion (F2.2, 30.5 = 3.529; p = 0.04) and perceived dyspnoea (F3, 42 = 3.753; 
p = 0.02). The variable of interest was the difference between trials at minutes 3, 5, 7 and 
10 (E3, E5, E7 and E10, respectively). There was a significant time effect for perceived 
exertion in both normal (F3, 42 = 38.113; p < 0.001) and hunched positions (F3, 42 = 63.134; 
p < 0.001) and for perceived dyspnoea in hunched position (F1.4, 19.3 = 30.192; p < 0.001). 
There was also a significant increase in perceived dyspnoea in normal condition but only 
between time points E3 and E7 (1.83 ± 0.28; p < 0.001), E3 and E10 (3.07 ± 0.51; p = 
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0.001), E5 and E7 (0.87 ± 0.17; p = 0.001) and E5 and E10 (2.10 ± 0.41; p = 0.01), where 




This study suggests that cycling for ten minutes with hunched shoulders does not result 
in a significant change in physiological markers of respiratory function, but it does lead 
to an increase in perception of breathing sensation, such as dyspnoea, assessed by using 
a Borg-CR10 scale in this study. 
 
The development of exertional dyspnoea is multifactorial. It may derive from both 
physiological and environmental factors (Wahls, 2012), but psychological factors such as 
affective state or attentional focus have also been demonstrated to considerably impact 
the perception of respiratory symptoms (Von Leupoldt et al., 2010). 
 
In this study, ratings of dyspnoea increased with the duration of the exercise in both C1 
and C2, including the lowest work rate, where no increase in ventilation occurred. 
Towards the end of the cycling trial, an intensification of dyspnoea was observed in the 
C2 position when compared to C1. Previous studies (el-Manshawi et al., 1986a, Leblanc 
et al., 1988) have shown that in a healthy population, the increase in respiratory effort, 
assessed by oesophageal pressure measurements, represents the increase in motor 
command. Gigliotto et al. (2010) previously reported that the effort required to sustain 
any given power increases with the duration with which the activity is sustained. 
Although neural drive was not assessed in this study, the observed phenomenon may be 
a reflection of an increase in motor command and inspiratory muscle effort (Grazzini et 
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al., 2005) due to the decreased respiratory volumes and shortened inspiratory time 
detected in hunched position. Previous studies have shown that in healthy humans the 
increase in effort dictated by exercise is related to the length of the test and represents the 
increase in motor command (Grazzini et al., 2005). The effort required to sustain any 
given power increases the longer the activity is sustained (Grazzini et al., 2005). 
 
Although it is important to assess the statistical significance of the differences between 
the evaluated conditions, another important factor to consider is, especially when 
investigating health and wellbeing, whether the findings provide information about the 
clinical relevance. With a large enough sample size, even the smallest, trivial differences 
between groups can become statistically significant. Although ratings of dyspnoea were 
statistically significantly higher in C2 condition in this study, it is not clear whether this 
difference is clinically important or meaningful to athletes or to their health support team. 
 
Quantifying dyspnoea through specific scales is essential in order to describe the level of 
discomfort and also to assess changes after intervention. A minimal clinically important 
difference (MCID) shows whether an intervention provides a minimum level of perceived 
benefit and moves beyond the concept of statistical differences (Cook, 2008). Although 
the Borg-CR10 scale has been widely used to assess breathing discomfort and dyspnoea 
in a sport setting, its MCID has not yet been defined. As highlighted in the previous 
chapters, the presentation of DB and the perception of breathing discomfort varies among 
athletes and therefore they should be evaluated on a case-by-case basis. MCIDs however, 
are average estimates obtained in groups of patients and may not be accurate reflections 
of an individualÕs perceived benefits.  
 
 115 
During exercise, an increase in VT generates an increase in end-inspiratory lung volumes, 
which forces the individual to breathe at higher volumes in the flat part of the pressure-
volume curve, but also increases the inspiratory pressure per breath, that is a function of 
maximal inspiratory pressure (MIP) (el-Manshawi et al., 1986b, O'Donnell et al., 1997). 
At high lung volumes, the maximal pressure-generating capacity decreases with the 
increase in velocity of muscle shortening for any given lung volume. In turn, during 
progressive exercise, pressure per breath to maximal pressure-generating capacity ratio 
increases in proportion to the sense of effort (O'Donnell et al., 1997). 
 
The results of this study show that in both conditions, the increase in ventilation was 
accomplished by increased respiratory frequency, however, in hunched position both the 
ventilation and the respiratory frequency reached a higher peak value. This could be 
explained by the biomechanics of the altered position. Cycling with hunched shoulders, 
by utilising the motor units that are best suited to the movements, may change the motor 
recruitment pattern of the respiratory muscles, which can possibly lead to increased 
respiratory work, and reduced mechanical performance of the respiratory system 
(Chaitow et al., 2014a). Consequently, an inefficient breathing pattern may lead to 
breathlessness that may be indicative of suboptimal function elsewhere than in the lungs 
and/or the larynx and may not even represent pathological condition (Johansson et al., 
2015). 
 
During spontaneous breathing normal inspiratory-expiratory ratio is 1:2, indicating that 
under normal circumstances the exhalation time is about twice as long as inhalation time 
(Van Diest et al., 2014). Increases in breathing frequency are brought about by reductions 
in both inspiratory and expiratory times (Tipton & American College of Sports Medicine, 
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2006). In this study, as expected, TiTo in both conditions increased slightly, but most of 
the total breath time remained in expiration and the inspiratory time was maintained at 




The non-significant differences observed between the two conditions may be due to one 
or a combination of the following three factors. Firstly, our participants were requested 
to maintain the altered body position throughout the cycling test, unlike in Òreal-lifeÓ DB, 
where athletes may only hunch their shoulders in the inspiratory phase of the breathing 
cycle.  Secondly, the study was performed on a cycle ergometer, where athletes are placed 
in a position with prolonged back flexion and rounded shoulders compared to a treadmill 
test where upright posture is guaranteed. Adding to it, Costa et al. (2011) reported that 
simple arm elevation modifies ventilatory and postural muscle recruitment, therefore, 
altering the mechanics of the ribcage and abdominal compartments. They found that 
inefficient movement pattern of paradoxical breathing, due to the consequentially 
modified rib cage position, results in an alteration in respiratory function and 
intensification of exercise effort. Thirdly and most importantly, as differences were 
observed towards the end of the cycling trials, we presume, that it is possible that the 
length (10 minutes) of the cycling trial was not sufficient to trigger an alteration in VT 
and BF, therefore in future a time trial or prolonged exercise test would be preferable in 







Cycling with hunched shoulders at high intensities, over a 10-minute period at 70% PAP 
is associated with higher ratings on the Borg-CR10 scale, however, the increased 
perception of dyspnoea was not accompanied by alterations in physiological markers of 
respiratory function. These findings suggest that the presence of respiratory discomfort 
may not be initiated by a ventilatory impairment, but likely to be related to the alterations 
of biomechanical properties caused by the distinctive body posture. Hence, a breath by 
breath gas analyser may not be useful as a diagnostic tool in the assessment of DB. Future 
studies should investigate whether altered shoulder positioning during exercise entails 
modifications in chest and abdominal motion and whether lung volume 




Chapter 7. Optoelectronic plethysmography 
(OEP) in the assessment of dysfunctional 



























Introduction: Ventilatory pattern and thoracic excursion, can vary during exercise and 
impact on ventilatory performance. A deviation away from an optimal trunk lumbo-pelvic 
recruitment pattern may affect lung volumes, work of breathing and may be relevant in 
the development of exertional dyspnoea.  
Aims and objectives: The aim of the study was to investigate the effect of different 
postural positions on the ventilatory excursion using OEP and a spirometer.  
Methods: Fifteen healthy male athletes (mean ± SD age: 30 ± 7 yr) completed the study. 
Ninety reflective markers were placed on the chest, abdomen and back. Participants 
performed baseline spirometric measurements and 10-minutes cycling challenges at an 
RPE of 17 in two conditions, in a randomised order: (C1) with normal shoulder position 
or (C2) with hunched shoulders, while undergoing simultaneous OEP data collection. 
Forced vital capacity and FEV1 were measured by the spirometer, whilst VT, BF and V̇E 
were assessed by the BbB analyser and data was gathered on the chest wall volume (CW) 
and the compartmental volumes of the rib cage (RC) and the abdomen (AB) by OEP.  
Results: The correlation between the two instruments in measuring FVC was good in 
both normal (r
2
 = 0.89) and hunched (r
2
 = 0.84) positions. FVC was significantly lower 
in hunched position during both spirometry (5.22 ± 0.69 L vs. 5.35 ± 0.69 L; p = 0.03) 
and OEP measurements (5.22 ± 0.62 L vs. 5.42 ± 0.69 L; p = 0.01). When volume 
contributions in the two conditions were compared, the RC/AB ratio was significantly 
lower in hunched position (1.84 ± 0.74 vs. 2.12 ± 0.79; p = 0.01). During the exercise 
challenge RC contribution was decreased and AB contribution was increased in C2 
throughout the test, although significant difference between the two conditions were only 
observed at the fifth minute of the cycling trial (E5) with RC values of 59.06 ± 10.01 % 
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vs. 57.23 ± 9.38 %; p = 0.01; in C1 and C2 respectively and AB values values of 41.56 ± 
10.32 % vs. 43.24 ± 9.33 %; p = 0.01; in C1 and C2 respectively. 
Conclusions: These findings suggest that respiratory excursion and lung volume 
compartmentalisation at both rest and during high intensity exercise are affected by the 
position of the shoulders. Specifically, a hunched should position leads to increased 
abdominal motion to vital capacity and decreased lung volumes. OEP may be a useful 






















Chapter 6 suggests that cycling with hunched shoulders at 70% of PAP over a 10-minute 
period is associated with increases in the perception of dyspnoea, without any alterations 
in physiological markers of respiration. Our findings also highlighted that posture may 
contribute to development of heightened exercise respiratory symptoms in the absence of 
cardio-pulmonary disease.  
 
The functional performance of the respiratory system during exercise is usually assessed 
with analysis of expired air to calculate BF, VT, V̇E, V̇O2 and V̇CO2. Although this 
method is commonly used and is valuable in the quantification of fitness status and 
diagnosis of a range of cardiovascular and respiratory diseases, (Albouaini et al., 2007) 
they provide no information of breathing pattern and/or lung volume recruitment, 
parameters, that may be of interest in the assessment of DB.  
 
Until recently the movement of the chest and abdomen during exercise has not been 
considered in either the understanding of optimal breathing pattern or in relation to 
exercise respiratory diseases (Hull et al., 2009). Although non-contact (e.g. SLP) (Levai 
et al., 2012) and contact (e.g. Respiratory inductive plethysmography; RIP) breath 
measurement methods (Jensen et al., 2014) have been utilised in recent years, they have 
limitations, such as requiring individuals to remain very still during the measurements, 
which make their application in exercise challenging. 
 
Optoelectronic plethysmography is an innovative method of indirect estimation of 
pulmonary ventilation, capable of breath-by-breath, three-dimensional, real-time 
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assessment of absolute lung volumes and their variations in the three compartments of 
the chest wall (pulmonary rib cage, abdominal rib cage and abdomen) (Parreira et al., 
2012). Optoelectronic plethysmography uses an optical reflectance motion analysis by 
computing the 3D coordinates of physical markers fixed on the chest and abdomen of 
studied subjects and allows the measurement of variables of breathing pattern, breathing 
asynchrony, and contribution of each chest wall compartment and hemithorax to the tidal 
volume (Parreira et al., 2012). The OEP system has been used in a variety of conditions 
including COPD, neuromuscular diseases, following thoracic surgical interventions, but 
also in intensive care patients and in newborns (Massaroni et al., 2017). The literature 
available on the use of OEP in exercise related respiratory kinematics is currently sparse. 
Investigations using OEP during exercise may assist our understanding of the relationship 
between posture, chest wall movement and exertional dyspnoea not explained by cardio-
pulmonary diseases. 
 
The aim of this study was therefore to investigate the effect of different postural positions 
on the respiratory system using OEP in conjunction with a spirometer (during forced 




7.3.1 Study design and participants 
 
As previously mentioned, OEP measurements were planned to be undertaken as part of 
the study described in Chapter 6. However, an OEP system was not available at my 
department at the time and setting up a short-term rental agreement with the provider of 
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the motion capture system took considerable time. This resulted in a 6-month delay in the 
project, during which a good number of participants had dropped out of the study and had 
to be replaced with newly recruited volunteers. Similar to the study in Chapter 6, healthy 
male participants aged between 18 - 40 years, who took part in endurance exercise at least 
twice a week were recruited through emails and poster advertisement to take part in the 
study. Endurance exercise is defined as a physical activity that increases heart rate and 
breathing frequency, such as running, swimming and cycling. Inclusion criteria included 
a score less than 23 on the NQ and a negative response to the EVH test, i.e. no evidence 
of airways hyper-reactivity or symptoms of DB.  
 
Individuals were excluded from the study if they had a chest infection within 4 weeks, any 
other illnesses within 2 weeks prior to the tests, had any respiratory or cardiovascular 
problems, metabolic diseases, neurological conditions, or if they were injured or had any 
conditions that limited mobility. On the test day, participants were instructed to come to 
the laboratory in a rested state, having abstained from high-intensity exercise within the 
previous 24 hours, and from food, alcohol, sports drinks or caffeine intake for the 
preceding three hours. The study was approved by the University Ethics Committee 
(Reference Number: Prop17_2013_14) and all participants provided written informed 
consent.  
 
7.3.2 Experimental design 
 
Due to the limited time available for the assessments (the OEP system was only loaned 
for a 2-weeks period) the study protocol used in Chapter 6 had to be modified in order to 
make its application feasible. Specifically, (1) participants did not have a pre-screening 
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visit, rather negative results on a previous EVH test, undertaken within one month, was 
accepted as a proof of airway health. (2) Participants did not perform a standardised 
incremental exercise test to determine PAP. Instead, a power output reached at an RPE 17 
level was assumed to comply with 70% of PAP.  
 
Participants attended the laboratory on a single occasion, during which they completed 
the NQ, and performed baseline spirometric measurements and 10-minutes cycling 
challenges at an RPE of 17. Both tests were performed in two different shoulder positions 
in a randomised order. Prior to starting the test, participants were given information on 
using the Borg 6 - 20 RPE scale. An overview of the experimental design is provided in 




Figure 7.1 Overview of the experimental design 
 
 
7.3.3 Study measurements 
 
7.3.3.1 Optoelectronic plethysmography (OEP) 
 
Ten IR cameras (Qualysis AB, Sweeden) were set up in a circular pattern over 360 
degrees, between 1 - 3 m from the participant (Figure 7.2) to capture the breathing related 
chest wall motion during exercise (Massaroni et al., 2015, Cala et al., 1996). 
 125 
 
Figure 7.2 Camera set up in the test laboratory 
 
Using anatomical reference points defined previously by Aliverti & Pedotti (2002), 90 
passive IR reflective markers with diameters of 6 and 9 millimetres were placed on the 
chest, abdomen and back. The markers were placed on a grid on the skin (Figure 7.3) 




Figure 7.3 Reflective markers placement on the torso 
 
The grid consisted of seven horizontal rows between the clavicles and the anterior superior 
iliac crest with additional bilateral columns in the mid-axillary line to create the anterior 
view. The rib cage (RC) was separated from the abdomen (AB) by the line of markers 
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placed on the lower edge of the chest. Seven posterior horizontal rows (between C7 and 
the posterior axillary lines) contributed to the coverage of the back (Layton, 2013). 
 
The RC was subdivided into two main compartments, namely the pulmonary rib cage 
(RCp) and the abdominal rib cage (RCa), by the transverse section at the level of the 
xiphoid. RCp extended from the clavicles to the line of markers spreading transversely at 
the level of the xiphisternum, while RCa extended from this line to the lower costal 
margin. The AB division covered the caudal parts of the frontal torso, from the lower 
costal margin to the level of the anterior superior iliac crest (Layton, 2013). 
 
Once the markers were positioned, the participant was seated on an upright cycle 
ergometer (Lode - Corival, Groningen, The Netherlands). Arms were positioned on 
supports at 90 degrees to the torso in the scapular plane in order to minimise upper body 
motion that could interfere with OEP data acquisition, and to maintain torso at 90 degrees 
of hip flexion. The IR cameras were positioned to ensure that all markers were visible by 
at least two infrared cameras, so the markersÕ three-dimensional position and 












Figure 7.4 Three-dimensional markers placement 
Panel A shows the markers placement on the front and Panel B shows the markers placement 
on the back of the torso 
 
OEP breathing assessments were performed and respiratory parameters were measured 
during forced expiratory manoeuvres using a spirometer (Figure 7.5A) and a flow 
measuring BbB analyser (Metalyzer© 3B, Cortex Biophysik GmbH, Germany) (Figure 
7.5B) and in the last 30 seconds of minutes 5, 7 and 10 of the 10-minutes cycling test at 





Figure 7.5 Study set up 
Panel A shows the participant during simultaneous spirometry measurements and Panel B 









, CareFusion, Germany 234 
GmbH), participants completed a minimum of three forced maximal flow-volume 
manoeuvres (Miller et al., 2005). For each maximal flow-volume manoeuvre, the 
following measurements were recorded in accordance to ATS/ERS 2005 Guidelines 
(Miller et al., 2005): FEV1 and FVC. 
 
7.3.3.3 Compartmental measurements 
 
The following indexes were used to evaluate the relationship between the different 
compartments of the torso: pulmonary rib cage and the abdominal rib cage (RCp/RCa), 
A. B. 
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the abdominal rib cage and the abdominal division (RCa/AB), the pulmonary rib cage and 
the abdominal division (RCp/AB) (Aliverti et al., 2004, Kenyon et al., 1997, Silvatti et 
al., 2012). A new index to measure distortions between the rib cage and the abdominal 
division (RC/AB) was also used. 
 
7.3.3.4 Exercise test at RPE 17 
 
Participants performed two aerobic exercise tests on a cycle ergometer (Lode - Corival, 
Groningen, The Netherlands). Participants were tested in two conditions; cycling with 
relaxed shoulders (C1; normal position) and cycling with lifted shoulders (C2; hunched 
position). The order of the cycling conditions was randomised.  
 
The test started with a 2-minutes warm up exercise at 50 W. During the first of the two 
cycling trials, the power output displayed on the screen of the exercise bike was only 
visible for the research team and participants were asked to choose the resistance blinded. 
After the warm-up, participants (without being able to see the display screen, and therefore 
having relied solely on their perception of effort) were instructed to increase the power 
output to a resistance that equals to ÒSomewhat hardÓ exercise level (RPE 13). This stage 
lasted for 2 minutes, after which participants were asked to increase the power so they 
reached an exercise level of ÒHard, HeavyÓ (RPE 15). They were instructed to cycle 2 
minutes at this level, before they increased the power output again to a ÒVery HardÓ 
exercise level (RPE 17). When participants reached this stage, they were instructed to 
cycle for 10 minutes at their previously set power output. The test ended with a 5-minutes 
recovery period. For the second cycling trial, the power outputs chosen by the participants 
in the first trial were used. Participants were instructed to maintain their preferred cadence 
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(60 - 90 RPM) throughout the test. Physiological markers of respiratory function were 
assessed throughout the test by using Metalyzer© 3B (Cortex Biophysik GmbH, 
Germany) BbB analyser. Taking simultaneous measurements was very much challenging. 
It required assistance: one person to operate the OEP system and another to run the CPET 
test, adjust the power output and ensure that markers were in place throughout the 
assessment. Also, prompt timing was crucial, in order to be able to sync the CPET data 
with the OEP output, the exact same time periods had to be recorded on both devices. 
Thus, it was not feasible to take any further measurements or collect any additional 
information (e.g. Borg-CR10 scores) during the cycling trials. 
 
An overview of the experimental protocol of Visit 3 and 4 is provided in Figure 7.6.  
 
 
Figure 7.6 Overview of the experimental protocol (C1 & C2 conditions) 
 
 
7.3.4 Statistical Analysis 
 
Data was assessed for normal distribution and sphericity of data were checked and 
parametric or non-parametric tests applied thereafter, as appropriate. The dependent 
variables analysed were: (1) Spirometer: FEV1, FVC; (2) BbB analyser: VT, BF, V̇E, 
TiTo, V̇O2, V̇CO2, RER and (3) OEP: RC, RCp, RCa and AB. Paired t-tests were used to 
assess differences of the variables between conditions. Statistical analysis was performed 
















Chicago, IL, USA). Normally distributed data were expressed as mean ± SD unless 




7.4.1 Participant characteristics 
 
Fifteen male participants (N = 13 Caucasians) completed the study. Participant 
characteristics are presented in Table 7.1.  
 
 
Table 7.1 Participant characteristics 
 





30 ± 7 
178.5 ± 5.8 




7.4.2 Lung volumes and compartmental contributions during forced expiratory 
manoeuvres  
 
Mean FVC values showed a difference between the normal (C1) and hunched (C2) 
shoulder positions with higher values in C1 (5.35 ± 0.69 L vs. 5.22 ± 0.69 L; p = 0.03). 
During the forced expiratory manoeuvres, RC and AB contributions differed between 
conditions; RC showed lower values (66.24 ± 7.48 % vs. 63.85 ± 8.01 %; p = 0.01) and 
AB showed higher values (33.76 ± 7.48 % vs. 36.15 ± 8.01 %; p = 0.01) in C2 when 
compared to C1 (Table 7.2). When RC compartments were examined separately, RCp 
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contributions differed between conditions and showed lower values in C2 (42.20 ± 7.55 
% vs. 39.75 ± 7.94 %; p = 0.01) (Table 7.2). 
 
Mean FEV1 values did not differ between conditions, however RC contribution was lower 
(65.76 ± 9.77 % vs. 62.15 ± 11.18 %; p < 0.001) and AB contribution higher (34.23 ± 
9.77 % vs. 37.85 ± 11.18 %; p < 0.001) in C2 (Table 7.3). When RC compartments were 
examined separately, we found that RCp contributions differed between conditions and 
showed lower values in C2 (41.17 ± 9.32 % vs. 38.85 ± 10.66 %; p = 0.04) (Table 7.2). 
 
 
Table 7.2 FVC and FEV1 values and related compartmental contributions 
(mean ± SD) during the forced expiratory manoeuvres in C1 and C2 
 
 Normal position (C1) Hunched position (C2) 
   
FVC (L) 5.35 ± 0.69 
a
 5.22 ± 0.69 
         OEP  Contributions   
RC (%) 66.2 ± 7.5 
a
 63.9 ± 8.0 
RCp (%) 42.2 ± 7.6 
a
 39.8 ± 7.9 
RCa (%) 24.0 ± 4.1 24.1 ± 5.1 
AB (%) 33.8 ± 7.5 
a
 36.1 ± 8.0 
   
FEV1 (L) 4.36 ± 0.65 4.35 ± 0.71 
           OEP  Contributions   
RC (%) 65.8 ± 9.8 
a
 62.2 ± 11.2 
RCp (%) 41.2 ± 9.3 
a
 38.8 ± 10.7 
RCa (%) 24.6 ± 4.6 23.3 ± 5.3 
AB (%) 34.2 ± 9.8 
a
 37.8 ± 11.9 
   
 
a







7.4.3 Lung volumes and compartmental contributions during exercise 
 
VE and BF increased in a similar pattern over time in both conditions with slightly higher 
values in C2 (Table 7.3). When the two conditions were compared, VT was lower in C2 
at the measured time points, however the difference was only significant at E5 (2.80 ± 
0.65 L vs. 2.68 ± 0.58 L; p = 0.01, in C1 and C2 respectively). Shoulder positioning had 
no effects on gas exchange parameters (Table 7.3).
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Table 7.3 Physiological parameters (mean ± SD) during the 10-minute cycling test (at minutes 5, 7 & 10) in C1 and C2 
 
                      Normal position (C1)  Hunched position (C2) 
Response 
variables 
minute 5  
(E5) 
minute 7  
(E7) 
minute 10  
(E10) 
 minute 5  
(E5) 




        
VT (L) 2.8 ± 0.7 
a
 2.7 ± 0.7 2.7 ± 0.6  2.7 ± 0.6 2.6 ± 0.6 2.6 ± 0.6 
BF (/min) 33 ± 8 37 ± 9 39 ± 9  35 ± 8 39 ± 9 42 ± 10 
V̇E (L/min) 89.4 ± 17.9 96.9 ± 19.6 100.3 ± 23.2  91.7 ± 20.2 98.9 ± 20.5 103.8 ± 24.9 
TiTo (%) 49 ± 5 48 ± 3 49 ± 3  49 ± 3 49 ± 3 49 ± 3 
V̇O2 (L/min) 2.8 ± 0.4 2.9 ± 0.4 3.0 ± 0.5  2.9 ± 0.5 3.0 ± 0.5 3.0 ± 0.5 
V̇CO2 (L/min) 3.0 ± 0.5 3.1 ± 0.5 3.1 ± 0.5  3.0 ± 0.5 3.1 ± 0.5 3.1 ± 0.5 
RER 1.05 ± 0.05 1.04 ± 0.05 1.03 ± 0.04  1.04 ± 0.05 1.03 ± 0.04 1.02 ± 0.05 
 
a
 Different from ÒC2Ó at corresponding time point (p ≤ 0.05) 
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RC contribution was decreased and AB contribution was increased in C2 throughout the 
test, although significant difference between the two conditions were observed only at E5 
with RC values of 59.06 ± 10.01 % vs. 57.23 ± 9.38 %; p = 0.01; in C1 and C2 
respectively and AB values values of 41.56 ± 10.32 % vs. 43.24 ± 9.33 %; p = 0.01; in 
C1 and C2 respectively (Table 7.4). At this time point, both RCp (39.90 ± 8.59 % vs. 
36.64 ± 8.36 %; p < 0.001, in C1 and C2 respectively) and RCa (19.16 ± 3.21 % vs. 20.59 
± 3.37 %; p = 0.02, in C1 and C2 respectively) differed significantly between conditions 
with RCp contributing less to the RC in C2 (Table 7.4). 
 
At E7, both RCp (39.90 ± 8.59 % vs. 36.64 ± 8.36 %; p < 0.001, in C1 and C2 
respectively) and RCa (19.16 ± 3.21 % vs. 20.59 ± 3.37 %; p = 0.02, in C1 and C2 
respectively) differed significantly between conditions, however this difference did not 
affect their contribution to the RC in either C1 or C2 (Table 7.4). 
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Table 7.4 Compartmental contributions (mean ± SD) during the 10-minute cycling test (at minutes 5, 7 & 10) in C1 and C2 
 
 
                      Normal position (C1)  Hunched position (C2) 
 minute 5  
(E5) 
minute 7  
(E7) 
minute 10  
(E10) 
 minute 5  
(E5) 
minute 7  
(E7) 





       
RC (%) 59.06 ± 10.01
 a
 57.38 ± 9.92 60.58 ± 8.92  57.23 ± 9.38 57.31 ± 9.70 57.97 ± 10.29 
RCp (%) 39.90 ± 8.59 
a
 38.99 ± 8.24 
a
 40.83 ± 8.18  36.64 ± 8.36 37.08 ± 7.71 37.14 ± 8.05 
RCa (%) 19.16 ± 3.21 
a
 18.89 ± 3.36 
a
 19.76 ± 3.11  20.59 ± 3.37 20.24 ± 3.75 20.83 ± 4.31 
AB (%) 41.56 ± 10.32 
a
 42.69 ± 9.90 40.06 ± 8.99  43.24 ± 9.33 43.73 ± 10.60 42.54 ± 10.44 




       
RCp/RCa 2.11 ± 0.44 
a
 2.10 ± 0.46 
a
 2.10 ± 0.49  1.82 ± 0.49 1.87 ± 0.43 1.83 ± 0.48 
RCa/AB 0.50 ± 0.17 0.47 ± 0.16 0.52 ± 0.16  0.50 ± 0.16 0.50 ± 0.19 0.53 ± 0.21 
RCp/AB 21.21 ± 8.96 
a
 21.83 ± 8.60 
a
 20.79 ± 9.44  26.50 ± 13.11 25.25 ± 11.62 25.38 ± 12.40 
RC/AB  1.56 ± 0.61 
a








The results of this study suggest that there is a difference in measures of spirometric 
indices and compartmental contributions between the two shoulder positions with a 
significant decrease in FVC and RB motion when subjects hunching their shoulders. This 
phenomenon was seen not only during maximal lung function assessments but also 
captured during exercise. 
 
The reduced vital capacity measured in hunched position indicates that athletes may 
achieve larger lung volumes during expiratory manoeuvres when in normal body position 
with straight back and relaxed shoulders. These results are in line with previous research 
of Chang et al. (2005), who demonstrated that an increase in energy expenditure due to 
hypertonic respiratory muscles may reduce ventilatory capacities. Our finding of reduced 
lung volumes is also in agreement with literature where McKeough et al. (2003) reported 
that arm movements could alter lung volumes; they suggested that arm position may 
change RB expansion and affect respiration.  
 
Forward shoulder position (FSP) is described as abduction and elevation of the scapula 
and a forward position of the shoulder, giving a caved-in appearance of the chest 
(Savadatti & Gaude, 2011). It can result from shoulder being pulled forward by 
overdeveloped, shortened and tight respiratory muscles such as the serratus anterior, 
pectoralis minor and intercostals or other shoulder girdle muscles, such as pectoralis 
major and upper trapezius muscles (Savadatti & Gaude, 2011). Our findings also support 
the results of the studies conducted by Ghanbari et al. (2008) and Savadatti et al. (2011) 
who found there was a significant correlation between FSP and respiratory values; 
respiratory parameters decline with increasing FSP degree (Ghanbari et al., 2008). They 
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suggested that FSP may decrease the expansion of the RC during inspiration (Ghanbari 
et al., 2008), increase the energy expenditure and the inability of the diaphragm to 
descend (Savadatti & Gaude, 2011) and reduce the compliance of the respiratory system 
(Ghanbari et al., 2008).  
 
Haas et al. (1982) and Appel et al. (1986) reported that altering the orientation of 
accessory muscles of respiration (as seen in FSP) has marked effects on the operating 
length and function of the diaphragm. Our results differ from these findings in that RCa 
did not change by the altered shoulder position, suggesting that either the diaphragmatic 
region was not affected by the change in upper body posture in our experimental set up 
or the upright cycling position with arms positioned on supports at 90¡ to the torso might 
have placed the participants in such an altered body position that the difference in 
compartmental contributions could not be detected between ÔnormalÕ and hunched 
conditions. Diaphragm electromyogram (EMGdi) is a valuable technique for the 
recording of electrical activity of the diaphragm (Estrada et al., 2016). The analysis of the 
EMGdi signal amplitude is an alternative approach for the indirect quantification of 
neural respiratory drive, which reflects the load on the respiratory muscles (Estrada et al., 
2016). Using this method during the exercise tests in order to confirm diaphragmatic 
activity would have been beneficial and recommended for future studies. 
 
In this study, ventilation increased in a similar pattern over time in both conditions. The 
ventilation in hunched position was achieved at a slightly reduced VT and a higher BF 
without any alterations in gas exchange parameters. The breathing motion in C2 is similar 
to that assessed in restrictive lung disease, where due to the reduced compliance, the work 
of breathing increases and individuals have to work harder to ventilate the lungs (Brown 
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et al., 2006). 
 
RC and AB contributions were significantly different in hunched position at the first 
assessed time point (E5), but not at later stages of the test. When RC contribution was 
divided into RCp and RCa, both parameters differed significantly between conditions, 
however RCp contributed less to the total RC volume in hunched position. This 
phenomenon may be explained by previous work of Illi et al. (2013) who reported that in 
altered body posture, the inspiratory and expiratory RC muscles have greater activation 
when compared to the diaphragm (Illi et al., 2013). At E7, both RCp and RCa differed 
significantly between conditions, however this difference did not affect their contribution 
to the total RC volume in neither of the cycling trials. No further differences were 
observed between conditions during the test, which might be due to the limitations 
described in 7.6.  
 
Although results were not conclusive, the percentage contributions and the coordination 
between compartments during breathing are assumed to be clinically and diagnostically 
relevant in DB, especially when the focus of interest is the optimisation of breathing 
mechanics in order to resolve symptoms. It is important to highlight, that each individual 
possesses their own characteristic breathing pattern, therefore when DB is suspected, 
assessment should be carried out on a case-by-case basis and treatment should aim to 








Although OEP provides important physiological information regarding chest wall motion 
and therefore it is the most promising approach in the assessment of DB, the technique 
has a number of limitations. (1) Marker placement is extremely time consuming, 
especially in individuals, in which landmarks are difficult to identify. (2) Although 
markers are attached to the skin using bi-adhesive tape, due to the extensive motion 
(especially at high intensities) and a consequent sweating during exercise, markers often 
fall off and are difficult to be physically replaced. (3) In our setup, in order to acquire 
optimal data with all markers visible for the duration of the test, participants were required 
to sit completely upright with arms in the scapular plane. Most participants found this 
position unnatural and difficult to maintain during prolonged, high intensity exercise. As 
a consequence, critical markers were blocked from camera view, resulting in data that 
was unable to be reconstructed and requiring virtual markers to be used. This unnatural 
position did not represent normal breathing, hence the difference between C1 and C2 may 




These findings suggest that respiratory excursion and lung volume compartmentalisation 
are affected by the position of the shoulders. Specifically, a hunched shoulder position 
leads to increased abdominal motion to vital capacity and decreased lung volumes. OEP, 
despite of its limitations, may be a useful tool to detect altered parameters associated with 
development of exertional dyspnoea and sub-optimal breathing mechanics.  
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Chapter 8. General Discussion 
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8.1 General Discussion 
 
It is clear that the findings from this thesis contribute to the limited available literature 
surrounding DB and highlight particular areas that warrant further research. Specifically, 
the main results of this thesis were threefold: (1) Chapter 4 demonstrated a very high 
prevalence (68%) of airway hyper-reactivity in elite level swimmers and revealed that a 
high proportion of athletes experiences exercise-induce respiratory symptoms in the lack 
of objective evidence of airway dysfunction. (2) Chapter 5 showed that the NQ, which at 
present is the most commonly applied diagnostic method for DB, has a low sensitivity in 
predicting a positive EVH challenge and differentiating EIB from DB in athletes. (3) 
Chapter 6 and 7 suggested that cycling for a prolonged period at high intensities with 
hunched shoulders does not result in significant changes in physiological markers of 
respiratory function, but triggers increased abdominal contribution to vital capacity and 
a subsequent increase in perception of breathing sensation. 
 
Athletes are particularly liable to injuries to the airway epithelium when they are 
requested to sustain high level exercise, with consequent high ventilation demand, 
especially when additionally exposed to unfavourable environmental conditions (i.e. cold 
dry air or chlorinated indoor pools) (Carlsen et al., 2008, Weiler et al., 2007, Moreira et 
al., 2011, Fitch, 2012, Dickinson et al., 2005). The findings from Chapter 4 support this 
notion, confirming the highest prevalence (68%) of airway dysfunction reported in elite 
swimmers. In contrast, in elite boxers, who are not exposed to the environmental stress 
of the pool environment (high concentrations of inhaled surface irritants such as chlorine 
gas derivatives), the prevalence of airway dysfunction was found to be nine fold lower 
(8%). It is important to note, that our cohort may have had greater exposure to triggers, 
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as they were part of an elite squad, in contrast to other studies (Parsons et al., 2007, 
Molphy et al., 2014, Mannix et al., 2004) that have only tested well-trained and/or sub-
elite athletes. It is also possible that some athletes, with a positive EVH test on the day of 
testing, could have a negative EVH result on a subsequent or second test. This 
acknowledged, the majority of the athletes tested positive had a fall in FEV1 > 15% (N = 
24; 73%) and in prior studies, test repeatability is improved in those with a fall of this 
severity or above (Price et al., 2015). 
 
It is claimed that dyspnoea is a prominent and disabling clinical characteristic of exercise-
induced airways dysfunction, such as EIB (Parsons et al., 2011). Although it can be 
diagnosed and managed effectively, the care that athletes suffering from this condition 
receive is often suboptimal. In this respect, it is apparent that the diagnosis of EIB is often 
made without objective evidence and in order to improve symptoms, athletes may be 
advised to reduce exercise intensity. At elite levels, this can result in withdrawing from 
competitive events and ultimately ending oneÕs sports career. 
 
Research in the past 20 years has highlighted an important, yet often overlooked fact, that 
there exists a weak association between the presence of conventional airway-centric 
symptoms (e.g. cough, wheeze and dyspnoea) and objective test confirmation of EIB 
(Rundell et al., 2001, Ansley et al., 2012, Nielsen et al., 2013). This poor relationship has 
been reinforced by the results of Chapter 4, that demonstrated a high prevalence of 
athletes, who reported respiratory complaints, despite having been tested negative on the 
EVH challenge. The fact, that half of these symptomatic EVH negative athletes had a 
previous diagnosis of asthma/EIB and were using one or a combination of short-acting 
β2-agonists, long-acting inhaled β2-agonists and inhaled corticosteroids, highlights an 
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important problem that health professionals, who encounter athletes with unexplained 
respiratory symptoms or symptoms that are ÒrefractoryÓ to treatment, face with and warns 
about the ÔdangerÕ of using solely a symptom-based method for diagnosis. The reason for 
this discrepancy has not yet been fully understood, but may relate to conditions that mimic 
EIB and not inevitably caused by underlying pathology.  
 
Identifying the cause of the perceived symptoms and distinguishing them from those 
originating from organic respiratory problems require careful evaluation, however, to 
date there exists no clear consensus on a gold standard assessment of this kind. In Chapter 
5, when evaluating the diagnostic performance of the NQ in distinguishing DB from EIB, 
self-reported symptoms on the NQ demonstrated only modest value in predicting clinical 
diagnosis. Three quarters of those athletes who scored under the cut-off value on the NQ, 
tested positive on the EVH challenge. One explanation for this might be an impaired 
symptom recognition including faulty perception of dyspnoea in elite athletes, especially 
in swimmers, who reportedly consider their exercise-induced symptoms as a normal 
effect of high-intensity training and consequently fail to report them (Turcotte et al., 
2003). Additionally, symptoms such as cough, wheeze and chest tightness may manifest 
in relation to cold air inhalation or only in provocative environments (e.g. chlorine 
exposure in swimming pools). Nearly half of all NQ positive individuals had a positive 
result on the EVH challenge, all of whom were elite athletes. In contrast, none of the NQ 
positive recreational athletes tested positive on the EVH challenge suggesting that to a 
certain extent, NQ may have a greater potential in differentiating EIB from DB in 




Although many of the studies assessing the epidemiology of DB use the NQ as a method 
of diagnosis, the questionnaire in its current form is Òneither disease or population-
specificÓ. The analysis in Chapter 5 has revealed a novel pattern of principal components 
both in terms of dimensional structure and items loading in physically active adolescents 
and suggested the possibility of removing five of the original questions from the 
questionnaire. In order to make the NQ specific to exercise and presumably more 
sensitive in identifying DB in athletes, a new questionnaire should be developed based 
on the previously described shortened version of the NQ and with the addition of 
questions related to psychosocial characteristics and sport specific respiratory symptoms.  
 
In order for a questionnaire to become clinically useful, it is important to assure that the 
instrument consistently measures what it purports to measure, when properly 
administered (Del Greco et al., 1987). When the focus of interest is in determining 
whether the scores satisfy a diagnosis, the questionnaire has to be assessed against a well-
established existing standard, a specific diagnostic criterion (e.g. objective evidence of a 
condition). In this context, to ensure that a newly developed symptoms questionnaire has 
the ability to predict DB in athletes, it should be stack up against another instrument or 
predictor. However, due to the lack of gold standard diagnostic tool for the identification 
of DB, a validation procedure of this kind is currently not possible. These findings suggest 
that, instead of symptom recognition, assessments should initially focus on the evaluation 
of the physiological and biomechanical characteristics of DB and the establishment of a 
gold standard diagnostic method.  
 
As highlighted in previous chapters, a high proportion of young athletes present with a 
breathing abnormality, which does not sit within the traditional clinical diagnosis and 
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cannot be defined through the standard assessment methods. In recent years, it has been 
proposed that certain triggers (e.g. high intensity aerobic exercise) can initiate a transition 
from a sporadic, altered breathing pattern, to a sustained disordered breathing, causing 
symptoms that are similar to those seen in EIB, but not linked to underlying pathology. 
 
It has been previously suggested (David et al., 2012) that stability of the body may be 
compromised in situations, in which respiratory demand increases and requires voluntary 
control. David et al. (2012) claimed that a functional link may exist between ventilation 
and posture control centres. They reported that an increase in tidal volume and breathing 
frequency during hyperventilation, is much more likely to change mass repartition of the 
trunk and to disturb posture. Although these findings suggest that voluntarily 
hyperventilation induces a wide range of posturographic perturbations, it is not known 
what happens to the respiratory parameters when an altered breathing pattern is 
maintained for a longer period of time. Thus Chapter 6 aimed to establish whether an 
alteration in body positioning profoundly influences breathing function and respiratory 
effort, when ventilatory requirements are increased. 
 
The results of Chapter 6 demonstrated that body posture during cycling at high intensity 
levels for a set period of time, has no significant effect on physiological markers of 
respiratory function, however it may lead to an increased perception of breathing 
sensation, such as dyspnoea. The intensified awareness of breathing detected in this study 
in the lack of physiological disturbances, may be indicative of suboptimal function 
elsewhere than in the respiratory tract and may not even represent pathological condition 
(Johansson et al., 2015). Inefficient breathing pattern with increased workloads, reduced 
mechanical advantage and increased ventilatory requirements may occur due to changes 
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in the optimal motor control of the respiratory muscles (O'Donnell et al., 2017), but 
detecting these alterations using breath by breath gas analysis techniques has proven not 
to be feasible and suggested that assessing the movement pattern changes related to body 
posture during exercise by using lung volume compartmentalisation techniques may be a 
better way to detect DB. 
 
Until recently the movement of the chest and abdomen during exercise has not been 
considered in either the understanding of optimal breathing pattern or in relation to 
exercise respiratory diseases (Hull et al., 2009, Massaroni et al., 2017). Although both 
non-contact (Levai et al., 2012) and contact (Jensen et al., 2014) breath measurement 
methods have been utilised in recent years, they have limitations, such as requiring 
individuals to remain very still during the measurements, which make their application in 
exercise challenging. In the last decade, OEP has taken the lead in the use of investigating 
chest wall kinematics and volume changes in the three compartments of the torso 
(Massaroni et al., 2017). This technique allows the study of both breathing volumes and 
biomechanical indexes for a better comprehension of the work of breathing without 
interferences using invasive instrumentation (Massaroni et al., 2017). 
 
Chapter 7 demonstrated that spirometric indices and compartmental contributions differ 
when body position is altered; a significant decrease in FVC and rib cage motion was 
observed when participants hunched their shoulders during the assessment. This 
phenomenon was seen not only during the maximal lung function tests but also captured 
during exercise. Furthermore, a significant difference in rib cage and abdominal 
contributions was detected when shoulders were hunched during cycling. Illi et al. (2013) 
previously reported that in altered body posture, the inspiratory and expiratory rib cage 
 148 
muscles have greater activation when compared to the diaphragm. This phenomenon was 
supported by our findings at the beginning of the assessment. When rib cage contribution 
was divided into two compartments (pulmonary and abdominal rib cage), we found that 
they both changed significantly with the alteration of body position, with the pulmonary 
rib cage contributing less to the total rib cage volume in hunched position. At a later stage, 
the motion of both rib cage compartments differed significantly between conditions, 
however this difference did not affect their contribution to the total rib cage volume in 
neither of the cycling trials. These findings suggest that respiratory excursion and lung 
volume compartmentalisation are affected by the position of the shoulders. Specifically, 
a hunched shoulder position leads to increased abdominal motion to vital capacity and 
decreased lung volumes. Although OEP provides important information regarding chest 
wall motion and therefore it is the most promising approach in the assessment of DB, the 
technique has a number of limitations, which must be resolved or at least reduced prior 
to undertaking further work in this field. 
 
8.2 Future directions 
 
Precise detection of distortions between compartmental contributions in exercising 
individuals may be a key element in the identification of DB and could potentially 
contribute towards the establishment of a gold standard diagnostic tool in this condition.  
Future research may want to consider the inclusion of additional cameras in order to 
assess individuals in a more natural cycling position and by doing so to allow the precise 
detection of distortions between compartmental contributions. Additionally, in order to 
support the easy application of the setup and reduce the processing time, a new marker 
set with lower number of markers would be beneficial to be developed.  
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Once a gold standard diagnostic method is established for the identification of DB, 
research could focus on the development of a DB specific symptom recognition 
instrument. This new questionnaire should be designed to have higher accuracy in 
identifying symptoms associated with exercise induced breathing impairment and to be 




Athletes who train and compete in provocative environments at a sustained high 
ventilation have an increased susceptibility to airway dysfunction. Additionally, a high 
proportion of athletes reports exercise-induced respiratory symptoms in the lack of 
objective evidence of airway dysfunction. Although NQ is currently the most commonly 
used diagnostic method for DB, it has a low sensitivity in predicting a positive EVH 
challenge and differentiating EIB from DB in athletes. Cycling with hunched shoulders 
at high intensities over a prolonged period does not result in significant changes in 
physiological markers of respiratory function, but leads to altered breathing mechanics 
and a consequential increase in the sensation of dyspnoea, without the presence of cardio-
pulmonary disease. Due to the nature of the alterations, it has been concluded, that DB 
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